1
|
Gao Y, Ye T, Wu LG, Xu Y, Wang X, Cheng XQ, Zhang YL, Wang YY, Fan XR, Zhao HT, Liu H, Chai XF, Zhang L, Wang MZ, Li NS, Lian XL. [The association between baseline TPOAb and/or TgAb positivity and thyroid immune-related adverse events in patients with malignancies following treatment with immune checkpoint inhibitors]. Zhonghua Yi Xue Za Zhi 2024; 104:963-969. [PMID: 38514346 DOI: 10.3760/cma.j.cn112137-20231011-00706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Abstract
Objective: To investigate the association between positive anti-thyroid peroxidase antibody (TPOAb) and/or anti-thyroglobulin antibody (TgAb) and the occurrence of thyroid immune-related adverse events (irAEs) in patients with malignant tumors who treated with immune checkpoint inhibitors (ICIs). Methods: A case-control study. A total of 116 patients with malignant tumor who received ICIs treatment and underwent thyroid function evaluation at Peking Union Medical College Hospital from January 2017 to April 2023 were enrolled retrospectively, including 77 males and 39 females, with a median age of (M(Q1, Q3)) 63.0 (55.0, 70.0) years. The patients were divided into the euthyroid group (n=58) and the thyroid irAEs group (n=58) according to whether thyroid irAEs occurred after ICIs treatment. The clinical characteristics and baseline anti-thyroid antibodies associated with the occurrence of thyroid irAEs after ICIs treatment in patients with malignant tumors were evaluated. Variables with statistical significance in univariate analysis were included in multivariate logistic regression model to analyze the risk factors for thyroid irAEs in patients with malignant tumors who received ICIs treatment. Results: In irAEs group, therewore 4 (3.4%) cases of clinical thyrotoxicosis, 23(19.8%) cases of subclinical thyrotoxicosis, 23 (19.8%) cases of clinical hypothyroidism, and 8(6.9%) cases of subclinical hypothyroidism. The positive rate of anti-thyroid antibodies at baseline in the thyrioid irAEs group was higher than that in the euthyroid group[16/58(27.6%)vs 3/58(5.2%),P=0.001]. After at least one course of ICIs treatment, the incidence of thyroid irAEs in patients with positive anti-thyroid antibodies at baseline was 84.2% (16/19), whereas it was 43.3% (42/97) in patients with negative anti-thyroid antibodies(P=0.001). Univariate logistic regression analysis showed that gender (OR=2.812, 95%CI:1.257-6.293), baseline thyroid autoantibodies were positive (OR=6.984, 95%CI: 1.909-25.547), baseline TgAb positivity (OR=8.909, 95%CI: 1.923-41.280), and baseline TPOAb positivity (OR=7.304, 95%CI: 1.555-34.308) were associated with thyroid irAEs (all P<0.05). Multivariate logistic regression analysis indicated that baseline TgAb positivity (OR=7.637, 95%CI: 1.617-36.072) was a risk factor for thyroid irAEs (P=0.01). Conclusions: The incidence of thyroid irAEs is higher in patients who are positive for baseline TPOAb and/or TgAb compared to those who are negative for TPOAb and TgAb. Patients with positive TgAb at baseline are at high risk of developing thyroid irAEs.
Collapse
Affiliation(s)
- Y Gao
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - T Ye
- Department of Endocrinology, the Forth Affiliated Hospital of Xinjiang Medical University, Urumqi 830061, China
| | - L G Wu
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - Y Xu
- Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - X Wang
- Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - X Q Cheng
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - Y L Zhang
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - Y Y Wang
- Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - X R Fan
- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - H T Zhao
- Department of Liver Surgery, Peking Union Medical College, Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - H Liu
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - X F Chai
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - L Zhang
- Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - M Z Wang
- Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - N S Li
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| | - X L Lian
- Department of Endocrinology, Key Laboratory of Endocrinology of the National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
| |
Collapse
|
2
|
Long LY, Chen YW, Deng RF, Jiang ZY, Zhang YL. [Application and research advances of delayed sural neurotrophic vascular flap for diabetic foot ulcers]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2024; 40:296-300. [PMID: 38548401 DOI: 10.3760/cma.j.cn501225-20231102-00173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/02/2024]
Abstract
Diabetic foot ulcer is one of the serious complications of diabetes. Diabetic wounds are of great difficulty to repair, causing a high amputation rate and a great burden to patients and their family members and society. Researches showed that the delayed sural neurotrophic vascular flap has a great effect in repairing diabetic foot ulcers. This article mainly reviewed the clinical status and research advances of the delayed sural neurotrophic vascular flap in repairing diabetic foot ulcers, intending to provide a reference for its application and research.
Collapse
Affiliation(s)
- L Y Long
- Burn Plastic Surgery and Wound Repair Medical Center, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y W Chen
- Burn Plastic Surgery and Wound Repair Medical Center, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - R F Deng
- Burn Plastic Surgery and Wound Repair Medical Center, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Z Y Jiang
- Burn Plastic Surgery and Wound Repair Medical Center, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y L Zhang
- Burn Plastic Surgery and Wound Repair Medical Center, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| |
Collapse
|
3
|
Zhang YL, Liu XJ, An Z. Effects of Soliton Creation on Transient Transport through a Polymer Chain. J Phys Chem B 2024; 128:1812-1817. [PMID: 38324304 DOI: 10.1021/acs.jpcb.3c08121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
By using a nonadiabatic molecular dynamics method combined with the hierarchical equations of motion, we have investigated the nonequilibrium transient transport through a conjugated polymer chain. The polymer chain is described by the Su-Schrieffer-Heeger model, and its two ends are coupled with metal electrodes of different chemical potentials. In order to present the evolutions of the electronic injection and transport in the real-time domain, we have mainly discussed the dynamic relaxation processes of the excited states and transient transport currents. It is found that due to the existence of electron-phonon couplings in the conjugated polymers, creation of solitons not only affects the time of the system achieving the steady state but also leads to periodical oscillations of the steady-state transport currents with time in our simulations. Furthermore, with increasing applied bias voltage, the steady-state transport electronic current increases, which proved that the creation of the solitons can assist the electronic transport. These results have shown that the creation of the excited states is important in understanding the transport properties in organic nanostructures.
Collapse
Affiliation(s)
- Y L Zhang
- Hebei Key Laboratory of Photoelectric Control on Surface and Interface, College of Science, Hebei University of Science and Technology, Shijiazhuang 050018, China
| | - X J Liu
- College of Physics, Hebei Advanced Thin Films Laboratory, Hebei Normal University, Shijiazhuang 050024, China
| | - Z An
- College of Physics, Hebei Advanced Thin Films Laboratory, Hebei Normal University, Shijiazhuang 050024, China
| |
Collapse
|
4
|
Zhou JH, Zhang YL, Li LF, Lu PL. [Correlation between prognostic nutritional index and pleural thickness with survival time of epithelial malignant pleural mesothelioma patients]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2024; 42:118-123. [PMID: 38403420 DOI: 10.3760/cma.j.cn121094-20230106-00011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/27/2024]
Abstract
Objective: To explore the role of prognostic nutritional index (PNI) and pleural thickness in the prognostic evaluation of patients with epithelial malignant pleural mesothelioma (MPM) . Methods: In April 2022, a retrospective analysis was conducted on the data and laboratory data of 41 patients with epithelial MPM admitted to the cardiothoracic surgery department of Chuxiong Yi Autonomous Prefecture People's Hospital from January 2018 to May 2021. Univariate and multivariate analysis were used to evaluate the relationships between total survival time, clinical characteristics, PNI and pleural thickness in patients. Results: The 41 patients were mostly male (26 cases, 63.4%) , with a median age of 55 years old. The main clinical manifestations were chest pain (53.7%) , bloody pleural effusion (75.6%) , and chest pain combined with bloody pleural effusion (36.6%) . The median survival time of patients with different TNM stage, efficacy after 4 cycles of chemotherapy, PNI, maximum pleural thickness after chemotherapy (post max) , sum of post max in 3 zones after chemotherapy (post sum) were statistically different (χ(2)=3.89, 14.51, 15.33, 4.33, 12.05, P<0.05) . Compared with patients with high PNI and post sum<32.26 mm, MPM patients with low PNI and post sum≥32.26 mm have higher risk of death, and the differences were statistically significant (HR=1.52, 95%CI: 1.75-11.93, P=0.002; HR=1.70, 95%CI: 1.84-16.23, P=0.002) . Conclusion: PNI and post sum can be used to predict the prognosis of patients with epithelial MPM.
Collapse
Affiliation(s)
- J H Zhou
- Department of Cardiothoracic Surgery, Chuxiong Yi Autonomous Prefecture People's Hospital, Yunnan Province, Chuxiong 675000, China
| | - Y L Zhang
- Anesthesia Department 1, Chuxiong Yi Autonomous Prefecture People's Hospital, Yunnan Province, Chuxiong 675000, China
| | - L F Li
- Department of Cardiothoracic Surgery, Chuxiong Yi Autonomous Prefecture People's Hospital, Yunnan Province, Chuxiong 675000, China
| | - P L Lu
- Department of Cardiothoracic Surgery, Chuxiong Yi Autonomous Prefecture People's Hospital, Yunnan Province, Chuxiong 675000, China
| |
Collapse
|
5
|
Cao XX, Zhang YL, Zhao SQ, Zhang Q, Chi ZL. [Clinical efficacy of posterior femoral muscle flaps combined with posterior femoral cutaneous nerve nutrient vessel flap and closed lavage in the treatment of stage Ⅳ ischial tuberosity pressure ulcers]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2024; 40:159-164. [PMID: 38418177 DOI: 10.3760/cma.j.cn501225-20231017-00115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2024]
Abstract
Objective: To explore the clinical efficacy of posterior femoral muscle flaps combined with posterior femoral cutaneous nerve nutrient vessel flap and closed lavage in the treatment of stage Ⅳ ischial tuberosity pressure ulcers. Methods: This study was a retrospective observational study. From March 2021 to March 2022, 15 patients with stage Ⅳ ischial tuberosity pressure ulcers who met the inclusion criteria were admitted to Dezhou Dongcheng Hospital, including 11 males and 4 females, aged 31 to 72 years. The pressure ulcer wound size ranged from 6.0 cm×4.5 cm to 10.0 cm×6.0 cm, with cavity diameters of 10-14 cm. Five cases were complicated with ischial tuberosity bone infection. After clearing the lesion, the biceps femoris long head muscle flap with an area of 10.0 cm×4.0 cm-18.0 cm×5.0 cm and the semitendinosus muscle flap with an area of 8.0 cm×4.0 cm-15.0 cm×5.0 cm combined with the posterior femoral cutaneous nerve nutrient vessel flap with an area of 6.5 cm×5.5 cm-10.5 cm×6.5 cm was transplanted to repair the pressure ulcer wound. The flap donor area was directly sutured, and the closed lavage with tubes inserted into the wound cavity was performed for 2-3 weeks. The postoperative survival of the muscle flaps and skin flaps, the wound healing of the donor and recipient areas were observed. The recurrence of pressure ulcers, the appearance and texture of flaps, and scar conditions of the donor and recipient areas were followed up. Results: All the muscle flaps and skin flaps in the 15 patients successfully survived after surgery. Two patients experienced incisional dehiscence at one week after surgery due to improper turning over, during which the incision in the recipient area was pressed on, and the wounds healed after dressing changes of 3 to 4 weeks; the wounds in the donor and recipient areas healed well in the other patients. All patients received follow-up after surgery. During the follow-up period of 6 to 12 months, none of the patients experienced pressure ulcer recurrence, and the texture, color, and thickness of the skin flaps closely resembled those of the surrounding skin at the recipient site, with only linear scar left in the donor and recipient areas. Conclusions: When using the posterior femoral muscle flaps combined with the posterior femoral cutaneous nerve nutrient vessel flap and closed lavage to treat stage Ⅳ ischial tuberosity pressure ulcers, the tissue flap can be used to fully fill in the dead space of the pressure ulcers. After treatment, the wound heals well, the appearance of the donor and recipient areas is better, and the pressure ulcers are less prone to reoccur.
Collapse
Affiliation(s)
- X X Cao
- Department of Hand and Foot Microsurgery, Dezhou Dongcheng Hospital, Dezhou 253000, China
| | - Y L Zhang
- Department of Hand and Foot Microsurgery, Dezhou Dongcheng Hospital, Dezhou 253000, China
| | - S Q Zhao
- Department of Hand and Foot Microsurgery, Dezhou Dongcheng Hospital, Dezhou 253000, China
| | - Q Zhang
- Department of Hand and Foot Microsurgery, Dezhou Dongcheng Hospital, Dezhou 253000, China
| | - Z L Chi
- Repair and Reconstruction Microsurgery, Xi'an Zhongde Orthopedic Hospital, Xi'an 710043, China
| |
Collapse
|
6
|
Li TY, Zhang YL, Zhou XL, Li B, Liu JF. [Advancements in the research of congenital anosmia]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2024; 59:180-186. [PMID: 38369800 DOI: 10.3760/cma.j.cn115330-20231010-00135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/20/2024]
Affiliation(s)
- T Y Li
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y L Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - X L Zhou
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - B Li
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| | - J F Liu
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
7
|
Zhou L, Wang JL, Wang XW, Li YW, Zou Z, Zhang YL, Lyu XD. [Clinical Value of Detecting ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia Based on High-Throughput Sequencing Technology]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2024; 32:262-268. [PMID: 38387932 DOI: 10.19746/j.cnki.issn.1009-2137.2024.01.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2024]
Abstract
OBJECTIVE To compare the efficacy and clinical value of high-throughput sequencing (HTS) and Sanger sequencing in detecting ABL kinase domain mutations in patients with chronic myeloid leukemia (CML). METHODS A total of 198 samples of 147 CML patients from July 2017 to March 2021 in Henan Cancer Hospital were collected and underwent high-throughput sequencing and Sanger sequencing to detect the mutations in ABL kinase domain, and the relevant clinical data were collected for comparative analysis. RESULTS The proportion of total mutations and ≥2 mutations detected by high-throughput sequencing were significantly higher than those detected by Sanger sequencing (P =0.01; P =0.046). ≥2 mutations were detected in 22 cases, of which 5 cases (22.7%) had compound mutations. High-throughput sequencing can detect low level mutations that cannot be detected by Sanger sequencing. In 198 samples, 25 (12.6%) were low level mutations, 33 (16.7%) were high level mutations and 10 (5.1%) were mixed high and low level mutations. In the analysis of related clinical factors, the total mutation rate and the low level mutation rate in the optimal period, failure period and warning period were gradually increased (total mutation rate, P =0.016; low level mutation rate, P =0.005). The mutation rate of the samples with additional chromosomal abnormalities was also significantly increased (P =0.009). The mutation rate of patients who received first- and second-line treatment was significantly lower than that of patients who received third- or higher-line treatment (P =0.006). Analysis based on variant allele frequency (VAF) of the mutation site was helpful to visually evaluate the clonal evolution status of TKI-resistance CML cells. CONCLUSION High-throughput sequencing is more sensitive and accurate than Sanger sequencing in mutation detection, which is helpful to accurately and visually evaluate TKI treatment response and optimize treatment strategy for CML.
Collapse
Affiliation(s)
- Ling Zhou
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Jun-Liang Wang
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Xian-Wei Wang
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Yang-Wei Li
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Zhe Zou
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Yan-Li Zhang
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Xiao-Dong Lyu
- Central Lab,The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China.E-mail:
| |
Collapse
|
8
|
Deng RF, Long LY, Chen YW, Jiang ZY, Jiang L, Zou LJ, Zhang YL. [Clinical repair strategy for ischial tuberosity pressure ulcers based on the sinus tract condition and range of skin and soft tissue defects]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2024; 40:64-71. [PMID: 38296238 DOI: 10.3760/cma.j.cn501225-20231114-00194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
Objective: To investigate the clinical repair strategy for ischial tuberosity pressure ulcers based on the sinus tract condition and range of skin and soft tissue defects. Methods: The study was a retrospective observational study. From July 2017 to March 2023, 21 patients with stage Ⅲ or Ⅳ ischial tuberosity pressure ulcers who met the inclusion criteria were admitted to the First Affiliated Hospital of Nanchang University, including 13 males and 8 females, aged 14-84 years. There were 31 ischial tuberosity pressure ulcers, with an area of 1.5 cm×1.0 cm-8.0 cm×6.0 cm. After en bloc resection and debridement, the range of skin and soft tissue defect was 6.0 cm×3.0 cm-15.0 cm×8.0 cm. According to the depth and size of sinus tract and range of skin and soft tissue defects on the wound after debridement, the wounds were repaired according to the following three conditions. (1) When there was no sinus tract or the sinus tract was superficial, with a skin and soft tissue defect range of 6.0 cm×3.0 cm-8.5 cm×6.5 cm, the wound was repaired by direct suture, Z-plasty, transfer of buttock local flap, or V-Y advancement of the posterior femoral cutaneous nerve nutrient vessel flap. (2) When the sinus tract was deep and small, with a skin and soft tissue defect range of 8.5 cm×4.5 cm-11.0 cm×6.5 cm, the wound was repaired by the transfer and filling of gracilis muscle flap followed by direct suture, or Z-plasty, or combined with transfer of inferior gluteal artery perforator flap. (3) When the sinus tract was deep and large, with a skin and soft tissue defect range of 7.5 cm×5.5 cm-15.0 cm×8.0 cm, the wound was repaired by the transfer and filling of gracilis muscle flap and gluteus maximus muscle flap transfer, followed by direct suture, Z-plasty, or combined with transfer of buttock local flap; and transfer and filling of biceps femoris long head muscle flap combined with rotary transfer of the posterior femoral cutaneous nerve nutrient vessel flap; and filling of the inferior gluteal artery perforator adipofascial flap transfer combined with V-Y advancement of the posterior femoral cutaneous nerve nutrient vessel flap. A total of 7 buttock local flaps with incision area of 8.0 cm×6.0 cm-19.0 cm×16.0 cm, 21 gracilis muscle flaps with incision area of 18.0 cm×3.0 cm-24.0 cm×5.0 cm, 9 inferior gluteal artery perforator flaps or inferior gluteal artery perforator adipofascial flaps with incision area of 8.5 cm×6.0 cm-13.0 cm×7.5 cm, 10 gluteal maximus muscle flaps with incision area of 8.0 cm×5.0 cm-13.0 cm×7.0 cm, 2 biceps femoris long head muscle flaps with incision area of 17.0 cm×3.0 cm and 20.0 cm×5.0 cm, and 5 posterior femoral cutaneous nerve nutrient vessel flaps with incision area of 12.0 cm×6.5 cm-21.0 cm×10.0 cm were used. The donor area wounds were directly sutured. The survival of muscle flap, adipofascial flap, and flap, and wound healing in the donor area were observed after operation. The recovery of pressure ulcer and recurrence of patients were followed up. Results: After surgery, all the buttock local flaps, gracilis muscle flaps, gluteus maximus muscle flaps, inferior gluteal artery perforator adipofascial flaps, and biceps femoris long head muscle flaps survived well. In one case, the distal part of one posterior femoral cutaneous nerve nutrient vessel flap was partially necrotic, and the wound was healed after dressing changes. In another patient, bruises developed in the distal end of inferior gluteal artery perforator flap. It was somewhat relieved after removal of some sutures, but a small part of the necrosis was still present, and the wound was healed after bedside debridement and suture. The other posterior femoral cutaneous nerve nutrient vessel flaps and inferior gluteal artery perforator flaps survived well. In one patient, the wound at the donor site caused incision dehiscence due to postoperative bleeding in the donor area. The wound was healed after debridement+Z-plasty+dressing change. The wounds in the rest donor areas of patients were healed well. After 3 to 15 months of follow-up, all the pressure ulcers of patients were repaired well without recurrence. Conclusions: After debridement of ischial tuberosity pressure ulcer, if there is no sinus tract formation or sinus surface is superficial, direct suture, Z-plasty, buttock local flap, or V-Y advancement repair of posterior femoral cutaneous nerve nutrient vessel flap can be selected according to the range of skin and soft tissue defects. If the sinus tract of the wound is deep, the proper tissue flap can be selected to fill the sinus tract according to the size of sinus tract and range of the skin and soft tissue defects, and then the wound can be closed with individualized flap to obtain good repair effect.
Collapse
Affiliation(s)
- R F Deng
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - L Y Long
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y W Chen
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Z Y Jiang
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - L Jiang
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - L J Zou
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y L Zhang
- Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| |
Collapse
|
9
|
Zhang YL, Yang B, Yu F, Liu Y, Si GY, He QZ. Acute Pancreatitis Complicated by Thrombosis in the Right Brachiocephalic Veins and Superior Vena Cava: A Case Report. Curr Med Imaging 2024; 20:e060623217708. [PMID: 37282658 DOI: 10.2174/1573405620666230606125505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 05/20/2023] [Accepted: 05/24/2023] [Indexed: 06/08/2023]
Abstract
BACKGROUND Acute pancreatitis (AP) is one of the most common digestive emergencies, and vascular complication is one of the primary reasons for death, with splanchnic venous thrombosis being the most common. Although extra-splanchnic venous thrombosis is rare, it carries the risk of life-threatening secondary pulmonary embolism. CASE PRESENTATION We have, herein, reported a case of AP complicated by rare brachiocephalic vein thrombosis and superior vena cava thrombosis. A 40 years old woman was diagnosed with severe AP for abdominal pain 21 days ago. The patient received symptomatic treatment, including acid suppression, enzyme suppression, lipid-lowering, fluid infusion, anti-infection, and continuous renal replacement therapy. The patient was discharged after symptomatic relief. Recently, the patient was admitted again for middle-upper abdominal pain and discomfort. On admission, her blood platelet, DDimer, fibrin degradation products (FDP), and triglyceride levels have been found to be increased; abdominal enhanced CT showed pancreatic necrosis and an accumulation of peripancreatic necrosis and fluid, while chest enhanced CT suggested thrombosis in the right brachiocephalic vein and superior vena cava. The patient, however, improved and was discharged after anticoagulation combined with insulin and trypsin inhibitors. CONCLUSION In diagnosing and treating AP, dynamic monitoring of D-dimer levels is necessary for the timely detection of the development of thrombotic complications.
Collapse
Affiliation(s)
- Yan-Li Zhang
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Bin Yang
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Fei Yu
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Yong Liu
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Guang-Yan Si
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Qi-Zhou He
- Department of Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| |
Collapse
|
10
|
Zhang YL, Xia XK, Zhang M. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression]. Zhonghua Fu Chan Ke Za Zhi 2023; 58:930-938. [PMID: 38123199 DOI: 10.3760/cma.j.cn112141-20230801-00029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
Abstract
Objective: To investigate the clinical significance of endothelin A receptor (ETAR) expression in high-grade serous ovarian carcinoma (HGSOC). To design ETAR carboxyl terminal (ETAR-C) amino acids derived polypeptide and to study the inhibitory effect on ovarian epithelial carcinoma cells in vitro. Methods: (1) A total of 126 patients who received surgical treatment and were diagnosed with HGSOC by postoperative pathological examination in Central Hospital of Xuzhou from January 1, 2007 to December 31, 2017 were selected. All patients had completed clinicopathological data and follow-up data. Cancer tissue samples were collected and ETAR mRNA expression in HGSOC tissues was detected by reverse transcript-PCR. The clinical significance was analyzed. (2) ETAR-C fusion polypeptide was designed based on the sequence of carboxyl terminal amino acids of ETAR, expressed and purified in vitro. The effects of ETAR-C fusion polypeptide on migration and invasion ability of ovarian cancer SKOV3 and CAOV3 cells were detected by scratch test and invasion test, respectively. The effect of ETAR-C fusion polypeptide on chemosensitivity of cisplatin-resistant ovarian cancer SKOV3/cDDP and CAOV3/cDDP cells was determined by methyl thiazolyl tetrazolium (MTT) colorimetric assay. The effect of ETAR-C fusion polypeptide on β-arrestin-1 expression in ovarian cancer SKOV3 and CAOV3 cells was detected by western blot. Results: (1) The relative expression level of ETAR mRNA in HGSOC tissues was 18.6±5.1. Patients with HGSOC were divided into high ETAR mRNA expression (n=76) and low ETAR mRNA expression (n=50) with 61.7% as cut-off value analyzed by X-Tile software. High expression of ETAR mRNA was significantly correlated with abdominal water volume, platinum drug resistance, and cancer antigen 125 (CA125) value in HGSOC patients (all P<0.05), but was not related to the age of patients with HGSOC and the size of postoperative residual lesions (all P>0.05). The 5-year progression free survival rates were 18.4% and 28.0%, and the 5-year overall survival rates were 38.2% and 52.0% in HGSOC patients with high and low ETAR mRNA expression respectively, there were statistically significant differences (P=0.046, P=0.034). (2) The results of scratch test and invasion test showed that the scratch healing rate and cell invasion rate of SKOV3 or CAOV3 cells treated with endothelin-1 (ET-1) and ET-1+ETAR-C were respectively compared, and the differences were statistically significant (all P<0.05). MTT assay showed that the inhibition rates of ETAR-C fusion polypeptide treated in SKOV3/cDDP and CAOV3/cDDP cells were significantly higher than those of control cells after the addition of 4, 6, 8, 10, 12, and 24 μg/ml cisplatin (all P<0.05). Western blot analysis showed that the relative expression levels of β-arrestin-1 in SKOV3 or CAOV3 cells treated with ET-1 and ET-1+ETAR-C were 1.85±0.09 and 1.13±0.09 (SKOV3 cells), 2.14±0.15 and 1.66±0.12 (CAOV3 cells), respectively. The differences were statistically significant (all P<0.05). Conclusions: The prognosis of HGSOC patients with high expression of ETAR mRNA is significantly worse than those with low expression of ETAR mRNA. ETAR might be a new target for HGSOC treatment. The ETAR-C fusion polypeptide that interferes with the interaction of ETAR and β-arrestin-1 has good inhibitory effect on ovarian cancer cells in vitro, and might have clinical application potential.
Collapse
Affiliation(s)
- Y L Zhang
- Department of Obstetrics and Gynecology, Central Hospital of Xuzhou, Xuzhou 221009, China
| | - X K Xia
- Department of Obstetrics and Gynecology, Central Hospital of Xuzhou, Xuzhou 221009, China
| | - M Zhang
- Department of Obstetrics and Gynecology, Central Hospital of Xuzhou, Xuzhou 221009, China
| |
Collapse
|
11
|
Zheng YY, Xie JL, Zhang YL, Zhou XG. [Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases]. Zhonghua Bing Li Xue Za Zhi 2023; 52:1144-1150. [PMID: 37899321 DOI: 10.3760/cma.j.cn112151-20230205-00094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/31/2023]
Abstract
Objective: To investigate the clinicopathologic features of progressively transformed germinal center-like follicular T-cell lymphoma (PTGC-like FTCL). Methods: The clinicopathologic data of 14 PTGC-like FTCL cases that were diagnosed at the Beijing Friendship Hospital Affiliated to the Capital Medical University from January 2017 to January 2022 were retrospectively collected. Clinicopathological features, immunophenotype, and Epstein-Barr virus (EBV) infection status were analyzed in these cases. Polymerase chain reaction (PCR) was performed to detect the clonal gene rearrangements of T cell receptor (TCR) and the immunoglobulin (Ig) in 10 and 8 cases, respectively. Results: The male to female ratio was 5∶2. The median age was 61 years (range 32-70 years). All patients had lymphadenopathy at the time of diagnosis. By using the Ann Arbor system staging, seven cases were classified as stage Ⅰ-Ⅱ, and seven cases as stage Ⅲ-Ⅳ. Seven cases had B symptoms, four cases had splenomegaly, and two cases had skin rash and pruritus. Previously, three cases were diagnosed as classic Hodgkin's lymphoma, three cases as small B-cell lymphoma, two cases as atypical lymphoid hyperplasia unable to exclude angioimmunoblastic T-cell lymphoma (AITL), one case as EBV-associated lymphoproliferative disorder, and one case as peripheral T-cell lymphoma (PTCL) associated with the proliferation of B cells. All the 14 cases showed that the large nodules were composed of mature CD20+, IgD+B lymphocytes admixed with small aggregates of neoplastic cells with pale to clear cytoplasm. Moreover, hyperplastic germinal centers (GCs) and Hodgkin/Reed-Sternberg-like (HRS-like) cells were seen within these nodules in two and five cases, respectively. The neoplastic cells expressed CD3 (14/14), CD4 (14/14), PD1 (14/14), ICOS (14/14), CD10 (9/14), bcl-6 (12/14), CXCL13 (10/14), and CD30 (10/14). The HRS-like cells in five cases expressed CD20 (2/5), PAX5 (5/5), CD30 (5/5), CD15 (2/5), LCA (0/5), OCT2 (5/5) and BOB1 (2/5). Moreover, neoplastic T cells formed rosettes around HRS-like cells. EBV-encoded RNA (EBER) in situ hybridization showed scattered, small, positive bystander B lymphocytes in 8/14 cases, including 3/5 cases containing HRS-like cells. All tested cases (including five with HRS-like cells) showed monoclonal TCR gene rearrangement and polyclonal Ig gene rearrangement. Conclusions: PTGC-like FTCL is a rare tumor originated from T-follicular helper cells. It could be distinguished from angioimmunoblastic T-cell lymphoma by the formation of follicular structure, and lack of follicular dendritic cell proliferation outside the follicles and the polymorphous inflammatory background. In addition, it should be differentiated from lymphocyte-rich classical Hodgkin's lymphoma and low-grade B cell lymphoma.
Collapse
Affiliation(s)
- Y Y Zheng
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - J L Xie
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - Y L Zhang
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - X G Zhou
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| |
Collapse
|
12
|
Zhang L, Yuan YC, Zhang YL, Shen L. [Incidence and related factors of chronic neuropathic pain in elderly patients after video-assisted thoracoscopic surgery]. Zhonghua Yi Xue Za Zhi 2023; 103:3268-3272. [PMID: 37926570 DOI: 10.3760/cma.j.cn112137-20230625-01062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/07/2023]
Abstract
Objective: To investigate the incidence and related factors of chronic neuropathic pain (CNP) in elderly patients after thoracoscopic surgery. Methods: A total of 463 elderly patients (aged≥60 years) who underwent elective video-assisted thoracoscopic surgery from November 2020 to May 2021 at Peking Union Medical College Hospital were prospectively recruited. Among them, 283 were males and 180 were females, with an average age of (66.6±4.8) years. Chronic postsurgical pain (CPSP) was assessed by telephone at 6 months after surgery, and then the patients with CNP were screened using the ID-pain scale. Multivariable logistic regression was used to analyze the related factors for CNP in elderly patients after thoracoscopic surgery. Results: The incidence of CPSP was 41.9% (194/463), and the incidence of CNP was 18.8% (87/463). Multivariable logistic regression analysis showed that incision number<3 (OR=0.385, 95%CI: 0.156-0.949, P=0.038) and intraoperative N2O inhalation (OR=0.506, 95%CI: 0.304-0.842, P=0.009) were protective factors for CNP in elderly patients after thoracoscopic surgery, but high numeric rating scale (NRS) score on the first day after surgery (OR=1.180, 95%CI: 1.056-1.318, P=0.003) was a risk factor. Conclusions: The incidence of CNP in elderly patients after thoracoscopic surgery is 18.8%. Incision number<3 and intraoperative N2O inhalation are protective factors for CNP, but high NRS score on the first day after surgery is a risk factor.
Collapse
Affiliation(s)
- L Zhang
- Department of Anesthesiology, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China
| | - Y C Yuan
- Department of Anesthesiology, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China
| | - Y L Zhang
- Medical Science Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China
| | - L Shen
- Department of Anesthesiology, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China
| |
Collapse
|
13
|
Zhang YL, Ran C, Xu C, Li W. Clinico-radiologic subtypes and therapeutic observation of acute Marchiafava-Bignami disease. Sci Rep 2023; 13:18516. [PMID: 37898646 PMCID: PMC10613259 DOI: 10.1038/s41598-023-45431-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 10/19/2023] [Indexed: 10/30/2023] Open
Abstract
We aimed to investigate the clinico-radiologic features of acute Marchiafava-Bignami disease (MBD) and its evolutionary process after effective treatment through subgroup comparison. The clinical and MRI data of 23 patients with acute MBD were retrospectively analyzed and divided into type A (12 cases, with entire callosal involvement) and type B (11 cases, with focal callosal involvement). The clinical assessments and MRI findings (before and after treatment) were compared between the two subtypes. Compared with type B, type A had lower MoCA (Montreal Cognitive Assessment) scores at admission (16.50 ± 1.73 vs 18.27 ± 1.68, P = 0.021) and were more common with extracallosal involvement (66.67% vs 18.18%, P = 0.036) and longer illness duration (18.3 ± 2.1 days vs 15.6 ± 2.4 days, P = 0.012). During the treatment, the residual lesion in the splenium was more common in type A (58.33% vs 9.09%, P = 0.027). After treatment, the MoCa scores of both subtypes gradually increased (P < 0.001), and the callosal and extracallasal lesions disappeared completely. Clinico-radiologic typing of acute MBD is related to the severity of early symptoms, but not to the prognosis. Complete clinico-radiologic recovery is possible for both subtypes with combined treatment. The clinico-radiologic reversibility is helpful for accurate diagnosis and therapeutic evaluation.
Collapse
Affiliation(s)
- Yan-Li Zhang
- Department of Clinical Pharmacy, Affiliated Hospital of Yangzhou University, Yangzhou, China
| | - Chao Ran
- Department of Radiology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China
| | - Chao Xu
- Department of Medical Imaging, Affiliated Hospital of Yangzhou University, No. 368, Hanjiang Middle Road, Hanjiang District, Yangzhou, 225100, China
| | - Wei Li
- Department of Medical Imaging, Affiliated Hospital of Yangzhou University, No. 368, Hanjiang Middle Road, Hanjiang District, Yangzhou, 225100, China.
| |
Collapse
|
14
|
Zhang X, Zhou XG, Yang M, Miao Y, Xing RG, Zheng YY, Zhang YL, Xie JL. [Clinicopathological analysis of EB virus-positive mucocutaneous ulcer]. Zhonghua Bing Li Xue Za Zhi 2023; 52:1037-1039. [PMID: 37805398 DOI: 10.3760/cma.j.cn112151-20230120-00058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/09/2023]
Affiliation(s)
- X Zhang
- Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
| | - X G Zhou
- Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
| | - M Yang
- Department of Pathology, Cangzhou Central Hospital, Cangzhou 061000, China
| | - Y Miao
- Department of Pathology, Cangzhou Central Hospital, Cangzhou 061000, China
| | - R G Xing
- Department of Pathology, Cangzhou Central Hospital, Cangzhou 061000, China
| | - Y Y Zheng
- Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
| | - Y L Zhang
- Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
| | - J L Xie
- Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
| |
Collapse
|
15
|
Hua X, Long ZQ, Wang SF, Xu F, Wang MD, Chen JY, Zhang YL, Ni W, Gao Y. Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys 2023; 117:e588-e589. [PMID: 37785781 DOI: 10.1016/j.ijrobp.2023.06.1936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Recent studies indicate that the novel lymphocyte-C-reactive protein ratio (LCR) is strongly associated with the survival of various tumors, but its prognostic value in nasopharyngeal carcinoma (NPC) is understudied. This study aimed to explore the relationship between the LCR and overall survival (OS) in NPC and to develop a predictive model. MATERIALS/METHODS A total of 841 NPC patients received concurrent chemoradiotherapy (CCRT) were retrospectively enrolled and randomly divided into training cohort (n = 589) and validation cohort (n = 252). Univariate and multivariate Cox analyses were performed to identify variables associated with OS and construct a predictive nomogram. The predictive accuracy of the nomogram was evaluated and independently validated. RESULTS The LCR score differentiated NPC patients into two groups with distinct prognoses (HR = 0.53; 95% CI: 0.32-0.89, P = 0.014). Multivariate analysis showed that age, T stage, N stage, EBV-DNA status, and LCR score were independently associated with OS and a predictive nomogram was developed. The nomogram had a good performance for the prediction of OS [C-index = 0.770 (95% CI: 0.675-0.864)] and outperformed the traditional staging system [C-index = 0.589 (95% CI: 0.385-0.792)]. The results were internally validated using an independent cohort. CONCLUSION The novel nutrition-inflammation marker of LCR could serve as a simplified, affordable, easy-to-obtain, non-invasive, and readily promotive prognostic marker for NPC patients received CCRT, and the LCR-based prognostic nomogram outperformed the conventional staging system in terms of predictive power.
Collapse
Affiliation(s)
- X Hua
- Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China
| | - Z Q Long
- State Key Laboratory of Oncology in South China, Guangzhou, China
| | - S F Wang
- SunYat-sen University Cancer Center, Guangzhou, China
| | - F Xu
- Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China
| | - M D Wang
- Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China
| | - J Y Chen
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Y L Zhang
- Jiangxi Provincial People's Hospital, Nanchang, China
| | - W Ni
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Y Gao
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| |
Collapse
|
16
|
Russo M, Monnin C, Zhang YL, Montreuil J, Tanzer M, Avizonis D, Hart A. A novel method for quantification of cefazolin local tissue concentration in blood, fat, synovium, and bone marrow using liquid chromatography - mass spectrometry. J Pharm Biomed Anal 2023; 234:115566. [PMID: 37441887 DOI: 10.1016/j.jpba.2023.115566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 06/26/2023] [Accepted: 07/05/2023] [Indexed: 07/15/2023]
Abstract
To be effective, the concentration of antibiotic used must exceed the minimum inhibitory concentration (MIC) against infecting organisms at and in the surgical site. Few studies follow antibiotic levels for tissues that are manipulated during surgery. The aim of this work was to develop and validate a novel LC-MS method as well as an efficient extraction technique for the quantification of cefazolin in local tissues and whole blood. This method uses the same efficient extraction method across multiple tissue types affected by orthopedic surgery: blood, fat, synovium, and bone marrow. The ability to quantify cefazolin in these tissues will help identify surgical techniques and antibiotic dosing protocols that better protect patients from infection. The internal standard, 13C2,15N-cefazolin, co-elutes with cefazolin, and was used in calibration curves and tissue extracts as well as for cefazolin recovery and matrix effects. The protocol was rigorously tested, including measurements of reproducibility and calibration curve quality. The recovery of the extraction method ranges from 94% to 113% across all sample types. There is little to no matrix effect on cefazolin signal (98-120%). The developed method was used to determine cefazolin concentrations in tissues of 10 patients undergoing a total knee replacement. Cefazolin blood concentrations were approximately 500 times higher than in adipose, synovium, and bone marrow tissues. This clinical data shows that although the minimum inhibitory concentration is largely surpassed in blood, the concentration of cefazolin in fat, synovium, and bone marrow could be insufficient during a knee replacement. This method of cefazolin quantification will help surgeons optimize antibiotic concentrations in the local tissues during knee replacement surgery and potentially reduce serious post-surgical infections.
Collapse
Affiliation(s)
- M Russo
- Metabolomics Innovation Resource, Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
| | - C Monnin
- Metabolomics Innovation Resource, Rosalind and Morris Goodman Cancer Institute, McGill University, Canada
| | - Y L Zhang
- Research Institute, McGill University Health Centre, Canada
| | - J Montreuil
- Division of Orthopedic Surgery, McGill University, Canada
| | - M Tanzer
- Division of Orthopedic Surgery, McGill University, Canada
| | - D Avizonis
- Metabolomics Innovation Resource, Rosalind and Morris Goodman Cancer Institute, McGill University, Canada.
| | - A Hart
- Division of Orthopedic Surgery, McGill University, Canada
| |
Collapse
|
17
|
Zhang XS, Liu BC, Du X, Zhang YL, Xu N, Liu XL, Li WM, Lin H, Liang R, Chen CY, Huang J, Yang YF, Zhu HL, Pan L, Wang XD, Li GH, Liu ZG, Zhang YQ, Liu ZF, Hu JD, Liu CS, Li F, Yang W, Meng L, Han YQ, Lin LE, Zhao ZY, Tu CQ, Zheng CF, Bai YL, Zhou ZP, Chen SN, Qiu HY, Yang LJ, Sun XL, Sun H, Zhou L, Liu ZL, Wang DY, Guo JX, Pang LP, Zeng QS, Suo XH, Zhang WH, Zheng YJ, Jiang Q. [To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:728-736. [PMID: 38049316 PMCID: PMC10630575 DOI: 10.3760/cma.j.issn.0253-2727.2023.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Indexed: 12/06/2023]
Abstract
Objective: To analyze and compare therapy responses, outcomes, and incidence of severe hematologic adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia (CML) . Methods: Data of patients with chronic phase CML diagnosed between January 2006 and November 2022 from 76 centers, aged ≥18 years, and received initial flumatinib or imatinib therapy within 6 months after diagnosis in China were retrospectively interrogated. Propensity score matching (PSM) analysis was performed to reduce the bias of the initial TKI selection, and the therapy responses and outcomes of patients receiving initial flumatinib or imatinib therapy were compared. Results: A total of 4 833 adult patients with CML receiving initial imatinib (n=4 380) or flumatinib (n=453) therapy were included in the study. In the imatinib cohort, the median follow-up time was 54 [interquartile range (IQR), 31-85] months, and the 7-year cumulative incidences of CCyR, MMR, MR(4), and MR(4.5) were 95.2%, 88.4%, 78.3%, and 63.0%, respectively. The 7-year FFS, PFS, and OS rates were 71.8%, 93.0%, and 96.9%, respectively. With the median follow-up of 18 (IQR, 13-25) months in the flumatinib cohort, the 2-year cumulative incidences of CCyR, MMR, MR(4), and MR(4.5) were 95.4%, 86.5%, 58.4%, and 46.6%, respectively. The 2-year FFS, PFS, and OS rates were 80.1%, 95.0%, and 99.5%, respectively. The PSM analysis indicated that patients receiving initial flumatinib therapy had significantly higher cumulative incidences of CCyR, MMR, MR(4), and MR(4.5) and higher probabilities of FFS than those receiving the initial imatinib therapy (all P<0.001), whereas the PFS (P=0.230) and OS (P=0.268) were comparable between the two cohorts. The incidence of severe hematologic adverse events (grade≥Ⅲ) was comparable in the two cohorts. Conclusion: Patients receiving initial flumatinib therapy had higher cumulative incidences of therapy responses and higher probability of FFS than those receiving initial imatinib therapy, whereas the incidence of severe hematologic adverse events was comparable between the two cohorts.
Collapse
Affiliation(s)
- X S Zhang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China
| | - B C Liu
- National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - X Du
- The Second People's Hospital of Shenzhen, Shenzhen 518035, China
| | - Y L Zhang
- Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - N Xu
- Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - X L Liu
- Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - W M Li
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - H Lin
- First Hospital of Jilin University, Changchun 130021, China
| | - R Liang
- Xijing Hospital, Airforce Military Medical University, Xi'an 710032, China
| | - C Y Chen
- Qilu Hospital of Shandong University, Jinan 250012, China
| | - J Huang
- The Fourth Affiliated Hospital of Zhejiang University, Hangzhou 322000, China
| | - Y F Yang
- Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - H L Zhu
- Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - L Pan
- Institute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - X D Wang
- Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu 610072, China
| | - G H Li
- Xi'an International Medical Center Hospital, Xi'an 710038, China
| | - Z G Liu
- Shengjing Hospital of China Medical University, Shenyang 110020, China
| | - Y Q Zhang
- The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
| | - Z F Liu
- The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - J D Hu
- Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - C S Liu
- First Hospital of Jilin University, Changchun 130021, China
| | - F Li
- The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - W Yang
- Shengjing Hospital of China Medical University, Shenyang 110020, China
| | - L Meng
- Tongji Hospital of Tongji Medical College, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - Y Q Han
- The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
| | - L E Lin
- Hainan General Hospital, Haikou 570311, China
| | - Z Y Zhao
- Hainan General Hospital, Haikou 570311, China
| | - C Q Tu
- Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China
| | - C F Zheng
- Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China
| | - Y L Bai
- Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China
| | - Z P Zhou
- The Second Hospital Affiliated to Kunming Medical University, Kunming 650106, China
| | - S N Chen
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China
| | - H Y Qiu
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China
| | - L J Yang
- Xi'an International Medical Center Hospital, Xi'an 710117, China
| | - X L Sun
- The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - H Sun
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
| | - L Zhou
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Z L Liu
- Huazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China
| | - D Y Wang
- Huazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China
| | - J X Guo
- The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - L P Pang
- Peking University Shenzhen Hospital, Shenzhen 516473, China
| | - Q S Zeng
- The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - X H Suo
- Handan Central Hospital, Handan 057150, China
| | - W H Zhang
- First Hospital of Shangxi Medical University, Taiyuan 300012, China
| | - Y J Zheng
- First Hospital of Shangxi Medical University, Taiyuan 300012, China
| | - Q Jiang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China
| |
Collapse
|
18
|
Zhang YL, Cai J, Pei YX, Liu HH, Lu RZ, Yang RD, Ma HL. [A survey of performance of public health risk assessment in emergencies of institutions for disease control and prevention at different levels in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:1462-1466. [PMID: 37743282 DOI: 10.3760/cma.j.cn112338-20230114-00031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/26/2023]
Abstract
Objective: To understand the performance of public health risk assessment in emergencies of institutions for disease control and prevention at different levels in China, and provide suggestions for the improvement of public health risk assessment. Methods: A self-administered survey was conducted in professionals involved in public health risk assessment in emergencies from national institution, provincial institutions and some prefectural institutions for disease control and prevention (1-2 prefectural institutions were selected using convenience sampling in each province) between March and April in 2021. Results: A total of 79 institutions for disease control and prevention were investigated, including 1 national institution, 32 provincial institutions and 46 prefectural institutions. By April 2021, all the 79 institutions surveyed had conducted risk assessment of public health emergencies, in which 61 (77.2%) had established departments responsible for the public health risk assessment, i.e. emergency management office or communicable disease prevention and control office (section), and regular risk assessment mechanisms. The main sources of information for public health risk assessment were public health surveillance systems, including the National Notifiable Diseases Reporting System (100.0%) and Public Health Emergencies Management Information System (97.5%). Compared with the provincial institutions, the prefectural institutions were more likely to use specific disease surveillance systems (84.8% vs. 62.5%; χ2=5.09, P=0.024). The risk management recommendations made by 43 institutions for disease control and prevention (54.4%) after the risk assessment were accepted by the superior health administrative departments and used in epidemic prevention and control. Conclusions: Public health risk assessment in emergencies has been widely carried out by national, provincial and prefectural institutions for disease control and prevention in China. Specialized departments and mechanisms have been established, but the information sources are still confined to public health surveillance systems and the application of the risk assessment results still needs to be further improved.
Collapse
Affiliation(s)
- Y L Zhang
- Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - J Cai
- Institute for Communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - Y X Pei
- Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - H H Liu
- Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - R Z Lu
- Institute for Communicable Disease Control and Prevention, Qingdao Prefectural Center for Disease Control and Prevention, Qingdao 266033, China
| | - R D Yang
- Emergency Management Office, Zhuhai Prefectural Center for Disease Control and Prevention, Zhuhai 519000, China
| | - H L Ma
- Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| |
Collapse
|
19
|
Yang XM, Wang XQ, Hu LP, Feng MX, Zhou YQ, Li DX, Li J, Miao XC, Zhang YL, Yao LL, Nie HZ, Huang S, Xia Q, Zhang XL, Jiang SH, Zhang ZG. Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis. Gastroenterology 2023; 165:629-646. [PMID: 37247644 DOI: 10.1053/j.gastro.2023.05.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 04/14/2023] [Accepted: 05/12/2023] [Indexed: 05/31/2023]
Abstract
BACKGROUND & AIMS Hyperactivation of ribosome biogenesis leads to hepatocyte transformation and plays pivotal roles in hepatocellular carcinoma (HCC) development. We aimed to identify critical ribosome biogenesis proteins that are overexpressed and crucial in HCC progression. METHODS HEAT repeat containing 1 (HEATR1) expression and clinical correlations were analyzed using The Cancer Genome Atlas and Gene Expression Omnibus databases and further evaluated by immunohistochemical analysis of an HCC tissue microarray. Gene expression was knocked down by small interfering RNA. HEATR1-knockdown cells were subjected to viability, cell cycle, and apoptosis assays and used to establish subcutaneous and orthotopic tumor models. Chromatin immunoprecipitation and quantitative polymerase chain reaction were performed to detect the association of candidate proteins with specific DNA sequences. Endogenous coimmunoprecipitation combined with mass spectrometry was used to identify protein interactions. We performed immunoblot and immunofluorescence assays to detect and localize proteins in cells. The nucleolus ultrastructure was detected by transmission electron microscopy. Click-iT (Thermo Fisher Scientific) RNA imaging and puromycin incorporation assays were used to measure nascent ribosomal RNA and protein synthesis, respectively. Proteasome activity, 20S proteasome foci formation, and protein stability were evaluated in HEATR1-knockdown HCC cells. RESULTS HEATR1 was the most up-regulated gene in a set of ribosome biogenesis mediators in HCC samples. High expression of HEATR1 was associated with poor survival and malignant clinicopathologic features in patients with HCC and contributed to HCC growth in vitro and in vivo. HEATR1 expression was regulated by the transcription factor specificity protein 1, which can be activated by insulin-like growth factor 1-mammalian target of rapamycin complex 1 signaling in HCC cells. HEATR1 localized predominantly in the nucleolus, bound to ribosomal DNA, and was associated with RNA polymerase I transcription/processing factors. Knockdown of HEATR1 disrupted ribosomal RNA biogenesis and impaired nascent protein synthesis, leading to reduced cytoplasmic proteasome activity and inhibitory-κB/nuclear factor-κB signaling. Moreover, HEATR1 knockdown induced nucleolar stress with increased nuclear proteasome activity and inactivation of the nucleophosmin 1-MYC axis. CONCLUSIONS Our study revealed that HEATR1 is up-regulated by insulin-like growth factor 1-mammalian target of rapamycin complex 1-specificity protein 1 signaling in HCC and functions as a crucial regulator of ribosome biogenesis and proteome homeostasis to promote HCC development.
Collapse
Affiliation(s)
- Xiao-Mei Yang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xiao-Qi Wang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Li-Peng Hu
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ming-Xuan Feng
- Department of Transplantation and Hepatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Yao-Qi Zhou
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Dong-Xue Li
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Jun Li
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xiao-Cao Miao
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Yan-Li Zhang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Lin-Li Yao
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Hui-Zhen Nie
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Shan Huang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Qiang Xia
- Department of Transplantation and Hepatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xue-Li Zhang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| | - Shu-Heng Jiang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| | - Zhi-Gang Zhang
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| |
Collapse
|
20
|
Ruan WY, Zhang YL, Zheng SG, Sun Y, Fan ZP, Song YL, Sun HC, Wang WM, Dai JW, Zhao ZJ, Zhang TT, Chen D, Pan YC, Jiang YG, Wang XD, Zheng LW, Zhu QL, He M, Xu BS, Jia ZL, Han D, Duan XH. [Expert consensus on the biobank development of oral genetic diseases and rare diseases and storage codes of related biological samples from craniofacial and oral region]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:749-758. [PMID: 37550034 DOI: 10.3760/cma.j.cn112144-20230523-00210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/09/2023]
Abstract
The biological samples of oral genetic diseases and rare diseases are extremely precious. Collecting and preserving these biological samples are helpful to elucidate the mechanisms and improve the level of diagnose and treatment of oral genetic diseases and rare diseases. The standardized construction of biobanks for oral genetic diseases and rare diseases is important for achieving these goals. At present, there is very little information on the construction of these biobanks, and the standards or suggestions for the classification and coding of biological samples from oral and maxillofacial sources, and this is not conducive to the standardization and information construction of biobanks for special oral diseases. This consensus summarizes the background, necessity, principles, and key points of constructing the biobank for oral genetic diseases and rare diseases. On the base of the group standard "Classification and Coding for Human Biomaterial" (GB/T 39768-2021) issued by the National Technical Committee for Standardization of Biological Samples, we suggest 76 new coding numbers for different of biological samples from oral and maxillofacial sources. We hope the consensus may promote the standardization, and smartization on the biobank construction as well as the overall research level of oral genetic diseases and rare diseases in China.
Collapse
Affiliation(s)
- W Y Ruan
- Clinic of Oral Rare Diseases and Genetic Diseases & Department of Oral Biology, School of Stomatology, The Fourth Military Medical University, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Xi'an 710032, China
| | - Y L Zhang
- Clinic of Oral Rare Diseases and Genetic Diseases & Department of Oral Biology, School of Stomatology, The Fourth Military Medical University, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Xi'an 710032, China
| | - S G Zheng
- Department of Preventive Dentistry, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - Y Sun
- Department of Oral Implantology, Stomatological Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai 200072, China
| | - Z P Fan
- Capital Medical University School of Stomatology & Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Beijing 100050, China
| | - Y L Song
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - H C Sun
- Department of Oral Pathology, Hospital of Stomatology, Jilin University, Changchun 130021, China
| | - W M Wang
- Department of Oral Mucosal Diseases, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China
| | - J W Dai
- Department of Oral and Craniomaxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China
| | - Z J Zhao
- The First Outpatient Department, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang 110002, China
| | - T T Zhang
- Department of Oral and Maxillofacial Surgery, Stomatological Hospital, Tianjin Medical University, Tianjin 300070, China
| | - D Chen
- Department of Polyclinics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - Y C Pan
- Department of Orthodontics, The Affiliated Stomatological Hospital of Nanjing Medical University & Jiangsu Province Key Laboratory of Oral Diseases & Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing 210029, China
| | - Y G Jiang
- Department of Cariology & Endodontics, College of Stomatology, Xi'an Jiaotong University, Xi'an 710004, China
| | - X D Wang
- Department of Oral and Craniomaxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China
| | - L W Zheng
- Deparment of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University & State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Chengdu 610041, China
| | - Q L Zhu
- Department of Operative Dentistry and Endodontics, School of Stomatology, The Fourth Military Medical University, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Xi'an 710032, China
| | - M He
- Deparment of Pediatric Dentistry, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - B S Xu
- Department of Oral and Maxillofacial Surgery, Institute of Stomatological Research, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University & Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510080, China
| | - Z L Jia
- Deparment of Cleft Lip and Palate Surgery, West China Hospital of Stomatology, Sichuan University & State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Chengdu 610041, China
| | - D Han
- Department of Prosthodontics, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - X H Duan
- Clinic of Oral Rare Diseases and Genetic Diseases & Department of Oral Biology, School of Stomatology, The Fourth Military Medical University, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Xi'an 710032, China
| |
Collapse
|
21
|
Wang W, Zhang YL, Huang L, Kang L. [Application of triangle stability mechanical model in the layer separation of transanal total mesorectal excision]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:603-606. [PMID: 37583015 DOI: 10.3760/cma.j.cn441530-20221028-00437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 08/17/2023]
Abstract
Transanal total mesorectal resection (taTME) has come a long way since it was first used in the clinic in 2010.The learning curve of this procedure is long due to different surgical approaches, different perspectives and different anatomical positions. Many surgeons experience complications during this procedure. Although the advantages and problems of this procedure have been reported in much literature, the anatomy and operation methods of taTME introduced in literatures and training centers are too complicated, which makes many surgeons encounter difficulties in carrying out taTME surgery. According to the author's experience in learning and carrying out this operation, spatial expansion process of ultralow rectal cancer was divided into three stages. At each stage, according to different pulling forces, three different schemes of triangular stability mechanics model were adopted for separation. From point to line, from line to plane, the model can protect the safety of peripheral blood vessels and nerves while ensuring total mesorectal excision . This model simplifies the complex surgical process and is convenient for beginners to master taTME surgical separation skills.
Collapse
Affiliation(s)
- W Wang
- General Surgery Department, Linyi Tumor Hospital, Linyi 276000, China
| | - Y L Zhang
- General Surgery Department, Linyi Tumor Hospital, Linyi 276000, China
| | - L Huang
- Colorectal and Anal Surgery Department, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China
| | - L Kang
- Colorectal and Anal Surgery Department, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China
| |
Collapse
|
22
|
Fan YF, Li ZP, Yu XJ, Li Z, Zhou HJ, Zhang YL, Gan XT, Hua D, Lu X, Kan B. [Study of the urban-impact on microbial communities and their virulence factors and antibiotic resistance genomes in the Nandu River, Haikou]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:974-981. [PMID: 37380422 DOI: 10.3760/cma.j.cn112338-20221229-01090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/30/2023]
Abstract
Objective: To explore the changes in bacterial community structure, antibiotic resistance genome, and pathogen virulence genome in river water before and after the river flowing through Haikou City and their transmission and dispersal patterns and to reveal anthropogenic disturbance's effects on microorganisms and resistance genes in the aquatic environment. Methods: The Nandu River was divided into three study areas: the front, middle and rear sections from the upstream before it flowed through Haikou City to the estuary. Three sampling sites were selected in each area, and six copies of the sample were collected in parallel at each site and mixed for 3 L per sample. Microbial community structure, antibiotic resistance, virulence factors, and mobile genetic elements were analyzed through bioinformatic data obtained by metagenomic sequencing and full-length sequencing of 16S rRNA genes. Variations in the distribution of bacterial communities between samples and correlation of transmission patterns were analyzed by principal co-ordinates analysis, procrustes analysis, and Mantel test. Results: As the river flowed through Haikou City, microbes' alpha diversity gradually decreased. Among them, Proteobacteria dominates in the bacterial community in the front, middle, and rear sections, and the relative abundance of Proteobacteria in the middle and rear sections was higher than that in the front segment. The diversity and abundance of antibiotic resistance genes, virulence factors, and mobile genetic elements were all at low levels in the front section and all increased significantly after flow through Haikou City. At the same time, horizontal transmission mediated by mobile genetic elements played a more significant role in the spread of antibiotic-resistance genes and virulence factors. Conclusions: Urbanization significantly impacts river bacteria and the resistance genes, virulence factors, and mobile genetic elements they carry. The Nandu River in Haikou flows through the city, receiving antibiotic-resistant and pathogen-associated bacteria excreted by the population. In contrast, antibiotic-resistant genes and virulence factors are enriched in bacteria, which indicates a threat to environmental health and public health. Comparison of river microbiomes and antibiotic resistance genomes before and after flow through cities is a valuable early warning indicator for monitoring the spread of antibiotic resistance.
Collapse
Affiliation(s)
- Y F Fan
- Department of Diarrheal Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - Z P Li
- Department of Diarrheal Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - X J Yu
- Inspection and Testing Institute, Hainan Center for Disease Control and Prevention, Haikou 570203, China
| | - Z Li
- Department of Diarrheal Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - H J Zhou
- Department of Diarrheal Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - Y L Zhang
- Inspection and Testing Institute, Hainan Center for Disease Control and Prevention, Haikou 570203, China
| | - X T Gan
- Inspection and Testing Institute, Hainan Center for Disease Control and Prevention, Haikou 570203, China
| | - D Hua
- Inspection and Testing Institute, Hainan Center for Disease Control and Prevention, Haikou 570203, China
| | - X Lu
- Department of Diarrheal Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - B Kan
- National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention/State Key Laboratory of Infectious Disease Prevention and Control, Beijing 102206, China
| |
Collapse
|
23
|
Sun L, Li P, Zhou XG, Teng XJ, Zheng YY, Zhang YL, Xie JL. [Clinicopathological features of fibrin-associated diffuse large B-cell lymphoma: a report of six cases]. Zhonghua Bing Li Xue Za Zhi 2023; 52:592-598. [PMID: 37263924 DOI: 10.3760/cma.j.cn112151-20230128-00075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Objective: To investigate the clinical, pathological and immunophenotypic features, molecular biology and prognosis of fibrin-associated large B-cell lymphoma (LBCL-FA) in various sites. Methods: Six cases of LBCL-FA diagnosed from April 2016 to November 2021 at the Beijing Friendship Hospital, Capital Medical University, Beijing, China and the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China were collected. The cases were divided into atrial myxoma and cyst-related groups. Clinical characteristics, pathological morphology, immunophenotype, Epstein Barr virus infection status, B-cell gene rearrangement and fluorescence in situ hybridization of MYC, bcl-2, bcl-6 were summarized. Results: The patients' mean age was 60 years. All of them were male. Three cases occurred in atrial myxoma background, while the others were in cyst-related background, including adrenal gland, abdominal cavity and subdura. All cases showed tumor cells located in pink fibrin clot. However, three cyst-related cases showed the cyst wall with obviously fibrosis and inflammatory cells. All cases tested were non germinal center B cell origin, positive for PD-L1, EBER and EBNA2, and were negative for MYC, bcl-2 and bcl-6 rearrangements, except one case with MYC, bcl-2 and bcl-6 amplification. All of the 5 cases showed monoclonal rearrangement of the Ig gene using PCR based analysis. The patients had detailed follow-ups of 9-120 months, were treated surgically without radiotherapy or chemotherapy, and had long-term disease-free survivals. Conclusions: LBCL-FA is a group of rare diseases occurring in various sites, with predilection in the context of atrial myxoma and cyst-related lesions. Cyst-related lesions with obvious chronic inflammatory background show more scarcity of lymphoid cells and obvious degeneration, which are easy to be missed or misdiagnosed. LBCL-FA overall has a good prognosis with the potential for cure by surgery alone and postoperative chemotherapy may not be necessary.
Collapse
Affiliation(s)
- L Sun
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - P Li
- Department of Pathology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China
| | - X G Zhou
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - X J Teng
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - Y Y Zheng
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - Y L Zhang
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| | - J L Xie
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
| |
Collapse
|
24
|
Li ZY, Zhao HF, Zhang YL, Song YP. [Efficacy of Tyrosine Kinase Inhibitor Combined with Decitabine, Homoharringtonine, Interferon in the Maintenance Therapy of Blast Phase Chronic Myeloid Leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2023; 31:649-653. [PMID: 37356921 DOI: 10.19746/j.cnki.issn.1009-2137.2023.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/27/2023]
Abstract
OBJECTIVE To explore the efficacy of tyrosine kinase inhibitor (TKI) combined with decitabine, homoharringtonine, and interferon regimen as maintenance therapy for blast phase chronic myeloid leukemia (CML-BP). METHODS The clinical data of CML-BP patients who received the first major hematological response after induction therapy at The Affiliated Cancer Hospital of Zhengzhou University from June 2015 to December 2021 were analyzed retrospectively. The event-free survival, duration of remission, and overall survival of patients in TKI combined with decitabine, homoharringtonine, interferon group(n=18) and TKI combined with conventional chemotherapy group(n=10) were compared by log-rank test. RESULTS A total of 28 patients were included, with a median age of 46 (24-58) years old. Kaplan-Meier survival analysis showed that patients in TKI combined with decitabine, homoharringtonine, interferon group had longer event-free survival (7.4 vs 4.3 months, P=0.043, HR=0.44, 95% CI: 0.17-1.14), duration of overall remission (16.1 vs 6.6 months, P=0.005, HR=0.32, 95% CI: 0.11-0.89), overall survival (34.3 vs 13.5 months, P=0.006, HR=0.29, 95% CI: 0.10-0.82) compared with patients in TKI combined with conventional chemotherapy group. CONCLUSION The TKI combined with decitabine, homoharringtonine and interferon regimen can significantly prolong the survival of CML-BP patients who obtained the major hematological response compared with TKI combined with conventional chemotherapy regimen.
Collapse
Affiliation(s)
- Zhi-Yue Li
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Hui-Fang Zhao
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Yan-Li Zhang
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China
| | - Yong-Ping Song
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China,E-mail:
| |
Collapse
|
25
|
Wu YX, Zhang YR, Jiang FJ, He S, Zhang YL, Chen D, Tong Y, Nie YJ, Pang QF. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition. Inflamm Res 2023:10.1007/s00011-023-01733-z. [PMID: 37169970 DOI: 10.1007/s00011-023-01733-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Revised: 04/03/2023] [Accepted: 04/11/2023] [Indexed: 05/13/2023] Open
Abstract
OBJECTIVES Pulmonary fibrosis (PF) is a chronic and refractory interstitial lung disease with limited therapeutic options. 4-octyl itaconate (4-OI), a cell-permeable derivative of itaconate, has been shown to have anti-oxidative and anti-inflammatory properties. However, the effect and the underlying mechanism of 4-OI on PF are still unknown. METHODS WT or Nrf2 knockout (Nrf2-/-) mice were intratracheally injected with bleomycin (BLM) to establish PF model and then treated with 4-OI. The mechanism study was performed by using RAW264.7 cells, primary macrophages, and conditional medium-cultured MLE-12 cells. RESULTS 4-OI significantly alleviated BLM-induced PF and EMT process. Mechanism studies have found that 4-OI can not only directly inhibit EMT process, but also can reduce the production of TGF-β1 by restraining macrophage M2 polarization, which in turn inhibits EMT process. Moreover, the effect of 4-OI on PF and EMT depends on Nrf2. CONCLUSION 4-OI ameliorates BLM-induced PF in an Nrf2-dependent manner, and its role in alleviating PF is partly due to the direct inhibition on EMT, and partly through indirect inhibition of M2-mediated EMT. These findings suggested that 4-OI has great clinical potential to develop as a new anti-fibrotic agent for PF therapy.
Collapse
Affiliation(s)
- Ya-Xian Wu
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
- Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Ya-Ru Zhang
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Feng-Juan Jiang
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Shuai He
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Yan-Li Zhang
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Dan Chen
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Ying Tong
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China
| | - Yun-Juan Nie
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China.
| | - Qing-Feng Pang
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, Jiangsu, People's Republic of China.
| |
Collapse
|
26
|
Yang S, Zhang X, Gale RP, Du X, Chen CY, Weng JY, Huang J, Li F, Zeng Y, Xiao Z, Hu JD, Yang LJ, Liu ZG, Li GH, Sun XL, Yang W, Feng R, Han YQ, Jing Y, Xu N, Liu XL, Liu ZF, Wang XD, Wu SX, Liang R, Zhang YL, Yang YF, Zhu HL, Pan L, Meng L, Zhao YH, Yi H, Liu YL, Zhang WH, Zheng YJ, Zhou ZP, Chen SN, Qiu HY, Li WM, Jia ZL, Bai YL, Lin LE, Liu BC, Liu CS, Luo JM, Meng JX, Sun ZQ, Zhang YQ, Huang XJ, Jiang Q. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol 2023. [PMID: 37128776 DOI: 10.1002/ajh.26943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Revised: 04/12/2023] [Accepted: 04/18/2023] [Indexed: 05/03/2023]
Affiliation(s)
- Sen Yang
- National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China
| | - Xiaoshuai Zhang
- National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China
| | - Robert Peter Gale
- Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK
| | - Xin Du
- Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
| | - Chun-Yan Chen
- Department of Haematology, Qilu Hospital, Shandong University, Jinan, China
| | - Jian-Yu Weng
- Department of Haematology, Guangdong Provincial People's Hospital, Guangzhou, China
| | - Jian Huang
- Department of Haematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China
- Department of Haematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Fei Li
- Center of Haematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Yun Zeng
- The First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Zhen Xiao
- The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China
| | - Jian-da Hu
- Fujian Medical University Union Hospital, Fuzhou, China
| | - Li-Jie Yang
- Xi'an International Medical Center Hospital, Xi'an, China
| | - Zhuo-Gang Liu
- Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
| | - Guo-Hui Li
- Xi'an International Medical Center Hospital, Xi'an, China
| | - Xiu-Li Sun
- Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Wei Yang
- Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
| | - Ru Feng
- Department of Hematology, Beijing Hospital, Beijing, China
| | - Yan-Qiu Han
- The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China
| | - Yu Jing
- Department of Hematology, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Na Xu
- Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Xiao-Li Liu
- Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Zhen-Fang Liu
- Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
| | - Xiao-Dong Wang
- Department of Haematology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China
- Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China
- Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China
| | - Shi-Xin Wu
- The Second Affiliated Hospital of Fujian Medical University, Fujian, China
| | - Rong Liang
- Department of Haematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Yan-Li Zhang
- Department of Haematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| | - Yun-Fan Yang
- Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China
| | - Huan-Ling Zhu
- Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China
| | - Ling Pan
- Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China
| | - Li Meng
- Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yan-Hong Zhao
- The First Affiliated Hospital, Harbin Medical University, Harbin, China
| | - Hai Yi
- Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China
| | - Yi-Lan Liu
- Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China
| | - Wei-Hua Zhang
- First Hospital of Shangxi Medical University, Shangxi, China
| | - Yuan-Jun Zheng
- First Hospital of Shangxi Medical University, Shangxi, China
| | - Ze-Ping Zhou
- Dept. of Hematology, The Second Hospital Affiliated to Kunming medical university, Kunming, China
| | - Su-Ning Chen
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China
| | - Hui-Ying Qiu
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China
| | - Wei-Ming Li
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Zhi-Lin Jia
- Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Yan-Liang Bai
- Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China
| | - Li-E Lin
- Hainan General Hospital, Hainan, China
| | - Bing-Cheng Liu
- National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
| | | | - Jian-Min Luo
- The Second Hospital of Hebei Medical University, Shijiazhuang, China
| | | | - Zhi-Qiang Sun
- Shenzhen Hospital of Southern Medical University, Shenzhen, China
| | - Yan-Qing Zhang
- Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Xiao-Jun Huang
- National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China
- Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
- Research Unit of Key Technique for Diagnosis and Treatments of Haematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China
| | - Qian Jiang
- National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China
- Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China
| |
Collapse
|
27
|
Cheng LY, Yang L, Li MM, Li YG, Zhang YL. [Pregnancy outcome analysis after radiofrequency ablation of monochorionic twin pregnancy in different gestational weeks and psychological intervention]. Zhonghua Yi Xue Za Zhi 2023; 103:1236-1241. [PMID: 37087408 DOI: 10.3760/cma.j.cn112137-20221108-02352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
Objective: To investigate the effect of different gestational weeks and psychological intervention on pregnancy outcome in patients with monochorionic twin pregnancy. Methods: The clinical data of 68 patients with monochorionic twin pregnancy in the middle and late pregnancy who were treated with radiofrequency ablation in the First Affiliated Hospital of Zhengzhou University from March 2017 to April 2021 were retrospectively analyzed, including 54 patients with single chorionic and single amniotic sac and 14 patients with single chorionic and double amniotic sac. Patients were divided into three groups according to the gestational weeks:<20 weeks (n=36), 20-23 weeks (n=17) and ≥24 weeks (n=15); and were divided into intervention group (n=40) and control group (n=28) according to the preoperative psychological intervention. The pregnancy outcome of patients with different pregnancy reduction and the effect of psychological intervention on pregnancy outcome was analyzed. Results: The age of 68 patients was (30.2±4.6) years old, the gestational age was (22.2±3.2) weeks, and 60 cases (88.2%) were live births after fetal reduction. There were no significant difference in age [(31.8±4.7),(28.3±5.0),(30.3±4.0) years old] (P=0.098), abortion rate, preterm birth rate, live birth rate, delivery mode, gestational week of preterm birth, gestational week of delivery, and neonatal weight between the two groups at different gestational weeks (all P>0.05). The ages of the intervention group and the control group were (30.6±4.7) and (29.4±4.0) years old (P=0.352). After psychological intervention for 40 patients in the intervention group, the anxiety score after pregnancy reduction was reduced from (54.8±6.8) to (37.3±7.3) (P<0.001), while the depression score decreased from (62.7±7.2) to (33.2±2.4) (P<0.001). Compared with patients in the control group (12.5%, n=5), the proportion of postoperative discomfort in the intervention group was higher (53.6%, n=15) (P<0.001). Compared with the control group, there were no statistically significant difference in the postoperative preterm birth rate, abortion rate, live birth rate, delivery mode, gestational week of preterm birth, gestational week of delivery, and neonatal weight in the intervention group (all P>0.05). Conclusions: Radiofrequency ablation is a safe and effective minimally invasive technique. For complex monochorionic twin pregnancies, early fetal reduction (<20 weeks) and preoperative psychological intervention can provide a solid guarantee for a good postoperative pregnancy outcome.
Collapse
Affiliation(s)
- L Y Cheng
- Reproductive Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - L Yang
- Reproductive Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - M M Li
- Reproductive Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - Y G Li
- Reproductive Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - Y L Zhang
- Reproductive Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| |
Collapse
|
28
|
Zhao F, Zhang YL, Liu X, Chen TH, Li J. [A case of malignant peritoneal mesothelioma]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2023; 41:307-309. [PMID: 37248188 DOI: 10.3760/cma.j.cn121094-20220328-00158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleural cavity, followed by the peritoneum and pericardium. Malignant peritoneal mesothelioma (MPM) accounts for 10%-15% of all mesothelioma. The most important risk factor for MPM is exposure to asbestos. MPM has no specific clinical symptoms, imaging and histopathology are critical for the diagnosis. There are currently no generally accepted guidelines for curative treatment of MPM. The patient mainly presented with abdominal pain, abdominal distension and discomfort. Due to extensive omentum metastasis, no further surgical treatment was performed. Pemetrexed combined with cisplatin chemotherapy was given for 2 cycles, and the patient is still alive.
Collapse
Affiliation(s)
- F Zhao
- General Surgery of Ziyang First People's Hospital, Ziyang 641300, China
| | - Y L Zhang
- General Surgery of Ziyang First People's Hospital, Ziyang 641300, China
| | - X Liu
- General Surgery of Ziyang First People's Hospital, Ziyang 641300, China
| | - T H Chen
- General Surgery of Ziyang First People's Hospital, Ziyang 641300, China
| | - J Li
- General Surgery of Ziyang First People's Hospital, Ziyang 641300, China
| |
Collapse
|
29
|
Zhu L, Lang JH, Ren C, Zhang YL, Chen DJ, Chen L, Chen YL, Cui MH, Di W, Duan H, Hao M, Huang XH, Li PL, Mao YD, Qi HB, Shi HR, Song L, Wang YF, Xu KH, Xu XX, Xue X, Yang HX, Yao SZ, Zhang GN, Zhang HW, Zhang SL, Zhou HM, Zhou YF, Zhu WG. [The Chinese guideline for prevention of pelvic and abdominal adhesions after obstetric and gynecologic surgery (2023 edition)]. Zhonghua Fu Chan Ke Za Zhi 2023; 58:161-169. [PMID: 36935192 DOI: 10.3760/cma.j.cn112141-20220822-00523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/21/2023]
|
30
|
Zhang YL, Yang Y, Saurer M, Schaub M, Gessler A, Lehmann MM, Rigling A, Walser M, Stierli B, Hajjar N, Christen D, Li MH. Sugar infusion into trees: A novel method to study tree carbon relations and its regulations. Front Plant Sci 2023; 14:1142595. [PMID: 36909442 PMCID: PMC9996627 DOI: 10.3389/fpls.2023.1142595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Accepted: 02/14/2023] [Indexed: 06/18/2023]
Abstract
Many carbon-related physiological questions in plants such as carbon (C) limitation or starvation have not yet been resolved thoroughly due to the lack of suitable experimental methodology. As a first step towards resolving these problems, we conducted infusion experiments with bonsai trees (Ficus microcarpa) and young maple trees (Acer pseudoplatanus) in greenhouse, and with adult Scots pine trees (Pinus sylvestris) in the field, that were "fed" with 13C-labelled glucose either through the phloem or the xylem. We then traced the 13C-signal in plant organic matter and respiration to test whether trees can take up and metabolize exogenous sugars infused. Ten weeks after infusion started, xylem but not phloem infusion significantly increased the δ13C values in both aboveground and belowground tissues of the bonsai trees in the greenhouse, whereas xylem infusion significantly increased xylem δ13C values and phloem infusion significantly increased phloem δ13C values of the adult pines in the field experiment, compared to the corresponding controls. The respiration measurement experiment with young maple trees showed significantly increased δ13C-values in shoot respired CO2 at the time of four weeks after xylem infusion started. Our results clearly indicate that trees do translocate and metabolize exogenous sugars infused, and because the phloem layer is too thin, and thus xylem infusion can be better operated than phloem infusion. This tree infusion method developed here opens up new avenues and has great potential to be used for research on the whole plant C balance and its regulation in response to environmental factors and extreme stress conditions.
Collapse
Affiliation(s)
- Yan-Li Zhang
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
- Department of Environmental Systems Science, Institute of Terrestrial Ecosystems, ETH Zürich, Zürich, Switzerland
| | - Yue Yang
- College of Ecology and Environment, Hainan University, Haikou, China
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Matthias Saurer
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Marcus Schaub
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Arthur Gessler
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
- Department of Environmental Systems Science, Institute of Terrestrial Ecosystems, ETH Zürich, Zürich, Switzerland
| | - Marco M. Lehmann
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Andreas Rigling
- Forest Dynamics, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
- Department of Environmental Systems Science, Institute of Terrestrial Ecosystems, ETH Zürich, Zürich, Switzerland
| | - Marco Walser
- Forest Soils and Biogeochemistry, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Beat Stierli
- Forest Soils and Biogeochemistry, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Noureddine Hajjar
- Forest Soils and Biogeochemistry, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Daniel Christen
- Forest Soils and Biogeochemistry, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland
| | - Mai-He Li
- College of Ecology and Environment, Hainan University, Haikou, China
- Key Laboratory of Geographical Processes and Ecological Security in Changbai Mountains, Ministry of Education, School of Geographical Sciences, Northeast Normal University, Changchun, Jilin, China
- College of Life Science, Hebei University, Baoding, Hebei, China
| |
Collapse
|
31
|
Li Q, Zhang XX, Hu LP, Ni B, Li DX, Wang X, Jiang SH, Li H, Yang MW, Jiang YS, Xu CJ, Zhang XL, Zhang YL, Huang PQ, Yang Q, Zhou Y, Gu JR, Xiao GGS, Sun YW, Li J, Zhang ZG. Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma. Nat Commun 2023; 14:861. [PMID: 36792623 PMCID: PMC9932171 DOI: 10.1038/s41467-023-36521-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 02/03/2023] [Indexed: 02/17/2023] Open
Abstract
To explore the mechanism of coadaptation and the potential drivers of pancreatic ductal adenocarcinoma (PDAC) metastasis to the liver, we study key molecules involved in this process and their translational value. Premetastatic niche (PMN) and macrometastatic niche (MMN) formation in a mouse model is observed via CT combined with 3D organ reconstruction bioluminescence imaging, and then we screen slit guidance ligand 2 (SLIT2) and its receptor roundabout guidance receptor 1 (ROBO1) as important factors. After we confirm the expression and distribution of SLIT2 and ROBO1 in samples from PDAC patients and several mouse models, we discover that SLIT2-ROBO1-mediated coadaptation facilitated the implantation and outgrowth of PDAC disseminated tumour cells (DTCs) in the liver. We also demonstrate the dependence receptor (DR) characteristics of ROBO1 in a follow-up mechanistic study. A neutralizing antibody targeting ROBO1 significantly attenuate liver metastasis of PDAC by preventing the coadaptation effect. Thus, we demonstrate that coadaptation is supported by the DR characteristics in the PMN and MMN.
Collapse
Affiliation(s)
- Qing Li
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.,Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China
| | - Xiao-Xin Zhang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.,Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, 212013, Jiangsu, P.R. China
| | - Li-Peng Hu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Bo Ni
- Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 1630, Dong Fang Road, Pu Dong New District, Shang Hai, 200127, Pu Dong, People's Republic of China
| | - Dong-Xue Li
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Xu Wang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Shu-Heng Jiang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Hui Li
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Min-Wei Yang
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China
| | - Yong-Sheng Jiang
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China
| | - Chun-Jie Xu
- Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 1630, Dong Fang Road, Pu Dong New District, Shang Hai, 200127, Pu Dong, People's Republic of China
| | - Xue-Li Zhang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Yan-Li Zhang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Pei-Qi Huang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Qin Yang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Yang Zhou
- Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, P.R. China
| | - Jian-Ren Gu
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China
| | - Gary Gui-Shan Xiao
- School of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian, P.R. China.,Functional Genomics and Proteomics Laboratory, Osteoporosis Research Center, Creighton University Medical Center, Omaha, NE, 68131, USA
| | - Yong-Wei Sun
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China.
| | - Jun Li
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
| | - Zhi-Gang Zhang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
| |
Collapse
|
32
|
Zhang YL, Su WZ, Ma CF, Xu ST. [Research progress on drug resistance of anti-varicella-zoster virus drugs]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:259-267. [PMID: 36797586 DOI: 10.3760/cma.j.cn112150-20220825-00839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Varicella-zoster virus (VZV) causes chickenpox when it first infects humans, and the virus may reactivate in adulthood and cause herpes zoster (HZ). Broad-spectrum antiviral drugs are one of the treatments for varicella and herpes zoster, but the emergence of drug resistance poses many challenges to this treatment and increases the burden of disease on patients. This paper discusses the resistance mechanisms, resistance sites and resistance detection methods of anti-VZV drugs in order to help further research on new anti-VZV targets, new drugs and monitoring of resistance to existing drugs.
Collapse
Affiliation(s)
- Y L Zhang
- School of Public Health, Shaanxi University of Chinese Medicine, Xianyang 712000, China
| | - W Z Su
- Department of Viral Immunization, Guangzhou Center for Disease Control and Prevention, Guangzhou 510000, China
| | - C F Ma
- School of Public Health, Shaanxi University of Chinese Medicine, Xianyang 712000, China Department of Virology, Xi'an Center for Disease Control and Prevention, Xi'an 710000, China
| | - S T Xu
- State Key Laboratory for Infectious Disease Prevention and Control,National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206,China
| |
Collapse
|
33
|
He J, Yan JJ, Zha X, Ding XJ, Zhang YL, Lu Z, Xu XH. Sexually dimorphic effects of estrogen receptor 2 deletion in the dorsal raphe nucleus on emotional behaviors. J Neuroendocrinol 2023; 35:e13195. [PMID: 36072992 DOI: 10.1111/jne.13195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 08/03/2022] [Accepted: 08/16/2022] [Indexed: 11/27/2022]
Abstract
Sex differences in emotional behaviors and affective disorders have been widely noted, of which sexually dimorphic secretion of gonadal steroid hormones such as estrogen is suspected to play a role. However, the underlying neural mechanisms remain poorly understood. We noted that the expression of estrogen receptor 2 (Esr2, or ERβ), a key mediator of estrogen signaling in the brain, was enriched in the dorsal raphe nucleus (DRN), a region involved in emotion regulation. To investigate whether DRN Esr2 expression confers sex-specific susceptibility or vulnerability in emotional behaviors, we generated a conditional allele of Esr2 that allowed for site-specific deletion of Esr2 in the DRN via local injection of Cre-expressing viruses. DRN-specific Esr2 deletion mildly increased anxiety behaviors in females, as shown by decreased time spent in the center zone of an open field in knockout females. By contrast, DRN Esr2 deletion had no effects on anxiety levels in males, as demonstrated by knockout males spending comparable time in the center zone of an open field and open arms of an elevated-plus maze. Furthermore, in the tail suspension test, DRN Esr2 deletion reduced immobility, a depression-like behavior, in a male-biased manner. Together, these results reveal sex-specific functions of DRN Esr2 in regulating emotional behaviors and suggest targeted manipulation of DRN Esr2 signaling as a potential therapeutic strategy to treat sex-biased affective disorders.
Collapse
Affiliation(s)
- Jing He
- Department of Psychiatry, Tongji Hospital of Tongji University, Tongji University School of Medicine, Shanghai, China
| | - Jing-Jing Yan
- Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China
| | - Xi Zha
- Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China
| | - Xiao-Jing Ding
- Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China
| | - Yan-Li Zhang
- Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China
| | - Zheng Lu
- Department of Psychiatry, Tongji Hospital of Tongji University, Tongji University School of Medicine, Shanghai, China
| | - Xiao-Hong Xu
- Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China
| |
Collapse
|
34
|
Luo ZD, Wang YF, Zhao YX, Yu LC, Li T, Fan YJ, Zeng SJ, Zhang YL, Zhang Y, Zhang X. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World J Gastroenterol 2023; 29:1-18. [PMID: 36683709 PMCID: PMC9850945 DOI: 10.3748/wjg.v29.i1.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2022] [Revised: 10/11/2022] [Accepted: 11/04/2022] [Indexed: 01/04/2023] Open
Abstract
Colorectal cancer (CRC) is one of the most common malignancies of the digestive tract, with the annual incidence and mortality increasing consistently. Oxaliplatin-based chemotherapy is a preferred therapeutic regimen for patients with advanced CRC. However, most patients will inevitably develop resistance to oxaliplatin. Many studies have reported that non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs, and circular RNAs, are extensively involved in cancer progression. Moreover, emerging evidence has revealed that ncRNAs mediate chemoresistance to oxaliplatin by transcriptional and post-transcriptional regulation, and by epigenetic modification. In this review, we summarize the mechanisms by which ncRNAs regulate the initiation and development of CRC chemoresistance to oxaliplatin. Furthermore, we investigate the clinical application of ncRNAs as promising biomarkers for liquid CRC biopsy. This review provides new insights into overcoming oxaliplatin resistance in CRC by targeting ncRNAs.
Collapse
Affiliation(s)
- Zheng-Dong Luo
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Yi-Feng Wang
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Yu-Xiao Zhao
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Long-Chen Yu
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Tian Li
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Ying-Jing Fan
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Shun-Jie Zeng
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Yan-Li Zhang
- Department of Clinical Laboratory, Shandong Provincial Third Hospital, Jinan 250012, Shandong Province, China
| | - Yi Zhang
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| | - Xin Zhang
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China
| |
Collapse
|
35
|
Qi JS, Su Q, Li T, Liu GW, Zhang YL, Guo JH, Wang ZJ, Wu MN. Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease. Neural Regen Res 2023; 18:727-733. [DOI: 10.4103/1673-5374.353479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
36
|
Cao Z, Aharonian F, An Q, Bai LX, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai JT, Cao Z, Chang J, Chang JF, Chen ES, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng HL, Cheng N, Cheng YD, Cui SW, Cui XH, Cui YD, D'Ettorre Piazzoli B, Dai BZ, Dai HL, Dai ZG, Della Volpe D, Duan KK, Fan JH, Fan YZ, Fan ZX, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng XT, Feng YL, Gao B, Gao CD, Gao LQ, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Gong GH, Gou QB, Gu MH, Guo FL, Guo JG, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He SL, He XB, He Y, Heller M, Hor YK, Hou C, Hou X, Hu HB, Hu Q, Hu S, Hu SC, Hu XJ, Huang DH, Huang WH, Huang XT, Huang XY, Huang Y, Huang ZC, Ji XL, Jia HY, Jia K, Jiang K, Jiang ZJ, Jin M, Kang MM, Ke T, Kuleshov D, Levochkin K, Li BB, Li C, Li C, Li F, Li HB, Li HC, Li HY, Li J, Li J, Li J, Li K, Li WL, Li XR, Li X, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JS, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Long WJ, Lu R, Luo Q, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Masood A, Min Z, Mitthumsiri W, Nan YC, Ou ZW, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Qi YQ, Qiao BQ, Qin JJ, Ruffolo D, Sáiz A, Shao CY, Shao L, Shchegolev O, Sheng XD, Shi JY, Song HC, Stenkin YV, Stepanov V, Su Y, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang ZB, Tian WW, Wang BD, Wang C, Wang H, Wang HG, Wang JC, Wang JS, Wang LP, Wang LY, Wang R, Wang RN, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang YP, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao DX, Xiao G, Xin GG, Xin YL, Xing Y, Xiong Z, Xu DL, Xu RX, Xue L, Yan DH, Yan JZ, Yang CW, Yang FF, Yang HW, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zeng ZK, Zha M, Zhai XX, Zhang BB, Zhang F, Zhang HM, Zhang HY, Zhang JL, Zhang LX, Zhang L, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang YL, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zheng Y, Zhou B, Zhou H, Zhou JN, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X, Ando S, Chianese M, Fiorillo DFG, Miele G, Ng KCY. Constraints on Heavy Decaying Dark Matter from 570 Days of LHAASO Observations. Phys Rev Lett 2022; 129:261103. [PMID: 36608208 DOI: 10.1103/physrevlett.129.261103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 08/19/2022] [Accepted: 10/27/2022] [Indexed: 06/17/2023]
Abstract
The kilometer square array (KM2A) of the large high altitude air shower observatory (LHAASO) aims at surveying the northern γ-ray sky at energies above 10 TeV with unprecedented sensitivity. γ-ray observations have long been one of the most powerful tools for dark matter searches, as, e.g., high-energy γ rays could be produced by the decays of heavy dark matter particles. In this Letter, we present the first dark matter analysis with LHAASO-KM2A, using the first 340 days of data from 1/2-KM2A and 230 days of data from 3/4-KM2A. Several regions of interest are used to search for a signal and account for the residual cosmic-ray background after γ/hadron separation. We find no excess of dark matter signals, and thus place some of the strongest γ-ray constraints on the lifetime of heavy dark matter particles with mass between 10^{5} and 10^{9} GeV. Our results with LHAASO are robust, and have important implications for dark matter interpretations of the diffuse astrophysical high-energy neutrino emission.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institut for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L X Bai
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - E S Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Long Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Q H Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S H Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H L Cheng
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - N Cheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B D'Ettorre Piazzoli
- Dipartimento di Fisica dell'Università di Napoli "Federico II," Complesso Universitario di Monte Sant'Angelo, via Cinthia, 80126 Napoli, Italy
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Z X Fan
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - K Fang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - B Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Q Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - J G Guo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X L Guo
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - H H He
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S L He
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X B He
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Y He
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - C Hou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S Hu
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - S C Hu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X J Hu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - D H Huang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W H Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z C Huang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H Y Jia
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - T Ke
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Levochkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Cong Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H B Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - K Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X R Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Xin Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Xin Li
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Z Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J L Liu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J S Liu
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - S M Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - W J Long
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Q Luo
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - H K Lv
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - A Masood
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Z Min
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - Y C Nan
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Z W Ou
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Y Pang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - M Y Qi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Q Qi
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - C Y Shao
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Y Shi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - B D Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - H Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - J S Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Y Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - R N Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Y Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y P Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Xia
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - G Xiao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - G G Xin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Z Xiong
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - F F Yang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H W Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Y H Yao
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Z K Zeng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M Zha
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X X Zhai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Lu Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - X P Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y L Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - Y Zheng
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - B Zhou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - X Zuo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Ando
- GRAPPA Institute, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
- Kavli Institute for the Physics and Mathematics of the Universe (KavliIPMU,WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - M Chianese
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
| | - D F G Fiorillo
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- Niels Bohr International Academy, Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - G Miele
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- Scuola Superiore Meridionale, Università degli studi di Napoli "Federico II", Largo San Marcellino 10, 80138 Napoli, Italy
| | - K C Y Ng
- Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China
| |
Collapse
|
37
|
Li CQ, Wang YC, Shen SQ, Zhang YL, Zhao JQ, Zou WB, Ge RL. Effects of exercise by type and duration on quality of life in patients with digestive system cancers: A systematic review and network meta-analysis. J Sport Health Sci 2022:S2095-2546(22)00122-3. [PMID: 36528289 PMCID: PMC10362486 DOI: 10.1016/j.jshs.2022.12.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Revised: 11/01/2022] [Accepted: 11/21/2022] [Indexed: 06/17/2023]
Abstract
BACKGROUND There is scant evidence regarding the effects of exercise type and duration on quality of life (QoL) in digestive system cancer (DSC) survivors. We aim to investigate the optimal type and duration of exercises to improve QoL for DSC survivors through a systematic review and network meta-analysis. METHODS A systematic literature search of PubMed, Embase, and Web of Science was performed. Eligibility for study inclusion was limited to studies that were randomized controlled trials involving all kinds of exercise in adult patients with DSCs, and the comparator was in standard care or other types of exercise. The primary outcome was QoL, including general health, physical health, mental health, and role function. Secondary outcomes included cancer-related symptoms such as fatigue, insomnia, depression, anxiety, and duration of hospital stay. The network meta-analyses were performed using a random-effect model. RESULTS The analysis included 32 eligible articles and a total of 2558 participants. Our primary outcome indicated that short-term aerobic exercise significantly enhanced general health (standardized mean differences (SMDs) = 0.66, 95% credible intervals (CrIs): 0.05 to 1.30, and also contributed to a better mental health (SMD = 0.37, 95%CrI: -0.06 to 0.81 and role function (SMD = 0.48, 95%CrI: -0.27 to 1.20). Although without significant changes, short-term resistance exercise tends to increase the physical health of patients with DSCs (SMD = 0.69, 95%CrI: -0.07 to 1.50) and effective in alleviating fatigue (SMD = -0.77, 95%CrI: -1.50 to 0.01). Short-term aerobic exercise was related to a lower score of insomnia (SMD = -1.20, 95%CrI: -2.40 to 0.06), depression (SMD = -0.51, 95%CrI: -1.50 to 0.45), and anxiety (SMD = -0.45, 95%CrI: -1.30 to 0.34). All types of exercise related to a trend of declined hospital stays (-0.87 to -5.00 days). Long-term resistance exercise, however, was negatively associated with general health (SMD = -0.33, 95%CrI: -1.70 to 1.00), physical health (SMD = -0.18, 95%CrI: -1.30 to 0.90), and role function (SMD = -1.20, 95%CrI: -2.50 to 0.11). CONCLUSION This study suggests that short-term aerobic exercise, with or without resistance exercise programs, enhances QoL (especially for general health) as well as relieves cancer-related symptoms for DSC survivors, while long-term resistance exercise may have negative effects, and thus should be adopted cautiously. These results provide important evidence for the management of DSCs.
Collapse
Affiliation(s)
- Chen-Qi Li
- Department of Nutrition, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China
| | - Yuan-Chen Wang
- National Clinical Research Center for Digestive Diseases, Department of Gastroenterology, Digestive Endoscopy Center, Changhai Hospital, Naval Medical University, Shanghai 200433, China
| | - Shu-Qun Shen
- Department of Outpatient, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China
| | - Yan-Li Zhang
- Department of Outpatient, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China
| | - Jie-Qiong Zhao
- Department of Outpatient, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China
| | - Wen-Bin Zou
- National Clinical Research Center for Digestive Diseases, Department of Gastroenterology, Digestive Endoscopy Center, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
| | - Rui-Liang Ge
- Department of Outpatient, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China.
| |
Collapse
|
38
|
Ning HJ, Ma X, Zhu D, Gong YZ, Yao KY, Zhang YL, Zhong XM. [Diagnostic value and application of 24 h multichannel intraluminal impedance-pH monitoring in children with gastroesophageal reflux disease]. Zhonghua Er Ke Za Zhi 2022; 60:1312-1316. [PMID: 36444436 DOI: 10.3760/cma.j.cn112140-20221028-00915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To evaluate the diagnostic value and application of 24 h multichannel intraluminal impedance-pH (24 h MII-pH) monitoring in children with gastroesophageal reflux disease (GERD). Methods: This is a cross-sectional study. From January 2013 to December, 2020, 417 patients who received 24 h MII-pH monitoring in Department of Gastroenterology of Children's Hospital Capital Institute of Pediatrics were included. According to results, these children were divided into the GERD and non-GERD groups. Furthermore, the 132 children with GERD who had gastroscopy were divided into the reflux esophagitis (RE) and non-erosive reflux disease (NE) groups to investigate the differences in their refluxes. Non-parametric Mann-Whitney U test or indepentent sample t test was used for comparisons between the groups. Results: Among the 417 children, 232 were males and 185 females, aged (7.3±3.9) years. The course of disease was 0.5 (0.1, 2.0) years. The main clinical symptoms included acid reflux (128 cases), vomiting (173 cases), abdominal pain (101 cases), and cough (76 cases). The 24 h MII-pH monitoring were positive in 243 children (58.3%, 243/417), which was higher than that by 24 h esophageal pH monitoring (43.6%, 182/417). The 24 h MII-pH monitoring results demonstrated significant differences in the episodes of acid reflux, weakly acidic reflux, non-acidic reflux, liquid reflux and mixed reflux between GERD and non-GERD groups (10 (4, 19) vs. 4 (1, 9) times/24 h, 14 (6, 32) vs. 7 (3, 13) times/24 h, 0 (0, 0) vs. 0 (0, 0) times/24 h, 19 (10, 34) vs. 8 (3, 14) times/24 h, and 6 (2, 12) vs. 3 (1, 5) times/24 h, Z=-6.96, -7.25, -5.62, -8.75, and -6.48, all P<0.05, respectively). Besides, the results also showed significant differences in Boix-Ochoa score, episodes of long reflux, course of long reflux, and episodes of weakly acidic reflux between the RE and NE groups (51.2 (21.4, 153.2) vs. 20.7 (12.1, 34.7), 5 (2, 10) vs. 1 (0, 4) times/24 h, 19 (7, 87) vs. 8 (3, 22) min, and 5 (2, 15) vs. 15 (6, 33) times/24 h, Z=-3.44, -3.41, -2.65, and -2.27, all P<0.05, respectively). Conclusion: 24 h MII-pH monitoring not only improves the detection rate of GERD in children, but also provides a possibility to early etiological diagnosis.
Collapse
Affiliation(s)
- H J Ning
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - X Ma
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - D Zhu
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - Y Z Gong
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - K Y Yao
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - Y L Zhang
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| | - X M Zhong
- Department of Gastroenterology, Children's Hospital,Capital Institute of Pediatrics, Beijing 100020, China
| |
Collapse
|
39
|
Zhang YL, Liu Y, Xia YL. [Interpretation of the 2022 ESC guidelines on cardio-oncology]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:1112-1117. [PMID: 36418282 DOI: 10.3760/cma.j.cn112148-20220927-00747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- Y L Zhang
- Department of Cardiology, First Affiliated Hospital of Dalian Meidcal University, Dalian 116011, China
| | - Y Liu
- Department of Cardiology, First Affiliated Hospital of Dalian Meidcal University, Dalian 116011, China
| | - Y L Xia
- Department of Cardiology, First Affiliated Hospital of Dalian Meidcal University, Dalian 116011, China
| |
Collapse
|
40
|
Dai MY, Zhang YL, Sun YX, Lyu X, Zhang XX, Sun XL, Fang FQ, Liu JW, Xia YL, Liu Y. [Cardiovascular events and risk factors in hematological neoplasms patients treated with anthracyclines]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:1058-1063. [PMID: 36418272 DOI: 10.3760/cma.j.cn112148-20220727-00584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To explore the incidence and risk factors of cardiovascular events in hematological neoplasms patients treated with anthracyclines in the real world. Methods: A total of 408 patients with lymphoma and leukemia, who were treated with anthracyclines during hospitalization in the First Affiliated Hospital of Dalian Medical University from January 1, 2018 to July 31, 2021, were included in this retrospective study. Patients were divided into cardiovascular event group (n=74) and non-cardiovascular event group (n=334). The primary endpoint was cardiovascular events (arrhythmia, heart failure, acute myocardial infarction etc.) after anthracyclines therapy. The secondary endpoint was all-cause mortality, cardiovascular-cause death, discontinued chemotherapy due to cardiovascular events. Multivariate regression analysis was used to investigate the risk factors of cardiovascular events. Kaplan-Meier was performed to calculate the incidence of all-cause mortality. Results: The mean age was (55.6±14.9) years, and there were 227 male patients (55.6%) in this cohort. The median follow-up time was 45 months. During follow-up, cardiovascular adverse events occurred in 74 patients (18.1%), including 45 heart failure (38 were heart failure with preserved ejection fraction), 30 arrhythmia, 4 acute myocardial infarction and 2 myocarditis/pericarditis. Multivariate regression analysis showed age (OR=1.024, 95%CI 1.003-1.045, P=0.027) and history of hypertension over 10 years (OR=2.328, 95%CI 1.055-5.134, P=0.036) were independent risk factors for the cardiovascular events. Kaplan-Meier survival curve showed mortality was significantly higher in cardiovascular event group than in non-cardiovascular event group (47.3% vs. 26.6%, P=0.001). In the cardiovascular event group, chemotherapy was discontinued in 9 cases (12.2%) due to cardiovascular events and cardiovascular death occurred in 7 cases (9.5%). Conclusions: Although heart failure is the main cardiovascular event in lymphoma and leukemia patients post anthracyclines therapy, other cardiovascular events especially arrhythmias are also common. The presence of cardiovascular events is associated with higher risk of all-cause mortality in these patients. Age and long-term hypertension are independent risk factors for cardiovascular events in lymphoma and leukemia patients after anthracyclines treatment.
Collapse
Affiliation(s)
- M Y Dai
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - Y L Zhang
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - Y X Sun
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - X Lyu
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - X X Zhang
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - X L Sun
- Department of Hematology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - F Q Fang
- Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - J W Liu
- Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - Y L Xia
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - Y Liu
- Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| |
Collapse
|
41
|
Zhang XR, Zhang YL. Progress in understanding of relationship between irritable bowel syndrome and food intolerance. Shijie Huaren Xiaohua Zazhi 2022; 30:886-891. [DOI: 10.11569/wcjd.v30.i20.886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder, and more and more studies have found that food intolerance is involved in the pathogenesis of IBS. About two-thirds of IBS patients experience clinical symptoms induced by food intolerance, including gastrointestinal symptoms such as abdominal pain, bloating, diarrhea, or constipation. A small number of patients also experience circulatory, respiratory, neurological, and other systemic symptoms. The exact mechanism by which food intolerance is involved in IBS is not fully understood. Common types of food intolerance include lactose intolerance, gluten intolerance, FODMAP intolerance, and histamine intolerance, among which lactose intolerance and FODMAP intolerance are more common in IBS patients. In this paper, we review the types of food intolerance in IBS and the role of food intolerance in the pathogenesis and intervention of IBS.
Collapse
Affiliation(s)
- Xiang-Rong Zhang
- School of Clinical Medicine, China-Japan Friendship Hospital, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Yan-Li Zhang
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
42
|
Li FF, Zhang YL, Guo DX, Zhao CJ, Yao YF, Lin YQ, Wang SQ. Biochemometric approach combined with 1D CSSF-TOCSY for the identification of sensitization agents in Curcuma longa L. and prediction of their action mechanisms. Microchem J 2022. [DOI: 10.1016/j.microc.2022.107727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
43
|
She Q, Zhen L, Fu F, Lei TY, Li LS, Li R, Wang D, Zhang YL, Jing XY, Yi CX, Zhong HZ, Tan WH, Li FG, Liao C. [Prenatal genetic diagnosis of the fetuses with isolated corpus callosum abnormality]. Zhonghua Fu Chan Ke Za Zhi 2022; 57:671-677. [PMID: 36177578 DOI: 10.3760/cma.j.cn112141-20220428-00281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To explore the application value of chromosome karyotype analysis, chromosomal microarray analysis (CMA) and whole exome sequencing (WES) in prenatal diagnosis of isolated corpus callosum abnormality (CCA) fetus. Methods: Fetuses diagnosed with isolated CCA by ultrasound and MRI and receiving invasive prenatal diagnosis in Guangzhou Women and Children's Medical Center and Qingyuan People's Hospital from January 2010 to April 2021 were selected. Karyotype analysis and/or CMA [or copy number variation sequencing (CNV-seq)] were performed on all fetal samples, and WES was performed on fetal samples and their parents whose karyotype analysis and/or CMA (or CNV-seq) results were not abnormal. Results: Among 65 fetuses with isolated CCA, 38 cases underwent karyotype analysis, and 3 cases were detected with abnormal karyotypes, with a detection rate of 8% (3/38). A total of 49 fetuses with isolated CCA underwent CMA (or CNV-seq) detection, and 6 cases of pathogenic CNV were detected, the detection rate was 12% (6/49). Among them, the karyotype analysis results were abnormal, and the detection rate of further CMA detection was 1/1. The karyotype results were normal, and the detection rate of further CMA (or CNV-seq) detection was 14% (3/21). The detection rate of CMA as the first-line detection technique was 7% (2/27). A total of 25 fetuses with isolated CCA with negative results of karyotyping and/or CMA were tested by WES, and 9 cases (36%, 9/25) were detected with pathogenic genes. The gradient genetic diagnosis of chromosomal karyotyping, CMA and WES resulted in a definite genetic diagnosis of 26% (17/65) of isolated CCA fetuses. Conclusions: Prenatal genetic diagnosis of isolated CCA fetuses is of great clinical significance. The detection rate of CMA is higher than that of traditional karyotyping. CMA detection could be used as a first-line detection technique for fetuses with isolated CCA. WES could increase the pathogenicity detection rate of fetuses with isolated CCA when karyotype analysis and/or CMA test results are negative.
Collapse
Affiliation(s)
- Q She
- Prenatal Diagnostic Center,the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, China
| | - L Zhen
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - F Fu
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - T Y Lei
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - L S Li
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - R Li
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - D Wang
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - Y L Zhang
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - X Y Jing
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - C X Yi
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - H Z Zhong
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - W H Tan
- Prenatal Diagnostic Center,the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, China
| | - F G Li
- Prenatal Diagnostic Center,the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, China
| | - C Liao
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| |
Collapse
|
44
|
Mao SD, Zhang M, Lin FH, Li XY, Zhao YY, Zhang YL, Gao YF, Luo J, Chen XD, Wang B. Attapulgite Structure Reset to Accelerate the Crystal Transformation of Isotactic Polybutene. Polymers (Basel) 2022; 14:polym14183820. [PMID: 36145968 PMCID: PMC9504820 DOI: 10.3390/polym14183820] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2022] [Revised: 09/08/2022] [Accepted: 09/08/2022] [Indexed: 11/16/2022] Open
Abstract
Isotactic polybutene (iPB) has a wide application in the water pipe field. However, the most valuable form I, needs 7 days to complete the transformation. In this study, the attapulgite (ATP), which produces lattice matching of the iPB form I, was selected to prepare an iPB/ATP composite. The Fischer–Tropsch wax (FTW) was grafted with maleic anhydride to obtain MAFT, and the ATP structure was reset by reactions with MAFT to the prepared FATP, which improved the interface compatibility of the ATP and iPB. The Fourier transform infrared spectroscopy (FT-IR) and the water contact angle test confirmed the successful synthesis of FATP. X-ray diffraction (XRD) verified that the graft of MAFT did not affect the crystal structure of ATP. The iPB + 5% FATP had the maximum flexural strength, which was 12.45 Mpa, and the flexural strength of the iPB + 5% FATP annealing for 1 day was much higher than others. Scanning electron microscope (SEM) photographs verified that FATP and iPB had good interface compatibility. The crystal transformation behavior indicated that the iPB + 5% FATP had the fastest crystal transformation rate, which proved that the reset structure, ATP, greatly accelerated the crystal transformation of iPB. This was a detailed study on the effect of lattice matching, interfacial compatibility and internal lubrication of the reset structure, ATP, in the nucleation and growth stages of iPB form I. The result was verified by XRD, differential scanning calorimetry (DSC), Avrami kinetics and polarizing microscope (POM) analysis.
Collapse
Affiliation(s)
- Shuang-Dan Mao
- School of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan 030024, China
| | - Mi Zhang
- Shanxi Province Institute of Chemical Industry Co., Ltd., Jinzhong 030621, China
- Shanxi Advance Technology Low Carbon Industry Research Institute Co. Ltd., Taiyuan 030021, China
| | - Fu-Hua Lin
- Shanxi Province Institute of Chemical Industry Co., Ltd., Jinzhong 030621, China
- Shanxi Advance Technology Low Carbon Industry Research Institute Co. Ltd., Taiyuan 030021, China
- Key Laboratory of Renewable Energy, Chinese Academy of Sciences, Guangzhou 510640, China
| | - Xiang-Yang Li
- Shanxi Province Institute of Chemical Industry Co., Ltd., Jinzhong 030621, China
- Shanxi Advance Technology Low Carbon Industry Research Institute Co. Ltd., Taiyuan 030021, China
| | - Yu-Ying Zhao
- School of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan 030024, China
| | - Yan-Li Zhang
- School of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan 030024, China
| | - Yi-Fan Gao
- School of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan 030024, China
| | - Jun Luo
- Guangzhou Fibre Product Testing and Research Institute, Guangzhou 510220, China
| | - Xin-De Chen
- Key Laboratory of Renewable Energy, Chinese Academy of Sciences, Guangzhou 510640, China
- Correspondence: (X.-D.C.); (B.W.); Tel.: +86-20-3721-3916 (X.-D.C.); +86-135-4647-4299 (B.W.)
| | - Bo Wang
- School of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan 030024, China
- Shanxi Advance Technology Low Carbon Industry Research Institute Co. Ltd., Taiyuan 030021, China
- Correspondence: (X.-D.C.); (B.W.); Tel.: +86-20-3721-3916 (X.-D.C.); +86-135-4647-4299 (B.W.)
| |
Collapse
|
45
|
Pang XM, Cai HH, Zhao J, Sun PY, Shi JJ, Zhang YL, Liu J, Liu ZC, Zheng X. Efficacy of astragalus in the treatment of radiation-induced lung injury based on traditional Chinese medicine: A systematic review and meta-analysis of 25 RCTs. Medicine (Baltimore) 2022; 101:e30478. [PMID: 36086738 PMCID: PMC10980465 DOI: 10.1097/md.0000000000030478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Accepted: 08/02/2022] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Astragalus (Hedysarum Multijugum Maxim., Huangqi) is a Chinese herbal medicine, and according to the theory of traditional Chinese medicine (TCM), Chinese medicinal preparations containing astragalus can be used clinically to treat radiation-induced lung injury (RILI). To systematically review the efficacy and safety of Chinese medicinal preparations containing astragalus in the prevention and treatment of RILI by means of meta-analysis. METHODS A systematic literature on randomized controlled trials (RCTs) of prescriptions containing astragalus in the treatment of RILI by Pubmed, Embase, Web of Science, Cochrane Library, China Biomedical Literature Database, China National Knowledge Infrastructure, China Science and Technology Journal Database, WANFANG Database. The retrieval time is from the establishment of the database to January 18, 2022. Meta-analysis, heterogeneity test and sensitivity analysis were performed on eligible RCTs using Revman 5.4 software and STATA 17.0 software, and a "funnel plot" was used to analyze potential publication bias. RESULTS A total of 25 RCTs were included, including 1762 patients, and the most widely used drugs were heat-clearing and detoxifying, yin-nourishing and qi-nourishing. The prescriptions containing astragalus can significantly reduce the total incidence of RILI (P < .01), improve the total effective rate and cure rate of RILI (P < .01), improve the quality of life of patients, alleviate breathing difficulties and reduce the expression of inflammatory factors (P < .01), and no adverse reactions related to TCM treatment were reported. CONCLUSION The traditional Chinese medicinal preparation containing astragalus can effectively alleviate the clinical symptoms of RILI, reduce the toxic side effects, and is safe to use in clinic.
Collapse
Affiliation(s)
- Xue-Meng Pang
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Hou-Hao Cai
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Jie Zhao
- Jinan Zhangqiu District Traditional Chinese Medicine Hospital, Jinan, China
| | - Ping-Yi Sun
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Jing-Jing Shi
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Yan-Li Zhang
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Juan Liu
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Zong-Chen Liu
- Shandong University of Traditional Chinese Medicine, Jinan, China
| | - Xin Zheng
- Qingdao Hospital of Traditional Chinese Medicine (Qingdao Hiser hospital), Qingdao, China
| |
Collapse
|
46
|
Jiang TT, Ji PH, He ZQ, Zhang YL, Deng Y, Chen X, Hong Y, Zhao DY, Zhang HW, Lin XM, Chen WQ. [Epidemic trend and control progress of taeniasis and cysticercosis in Henan Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2022; 34:547-551. [PMID: 36464252 DOI: 10.16250/j.32.1374.2021280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Henan Province is one of the provinces where taeniasis and cysticercosis were historically highly prevalent, and Taenia solium is the dominant species of tapeworm. Following the concerted efforts since 1970s, the prevalence of human taeniasis and cysticercosis has been maintained at a low level in Henan Province, which facilitates the national taeniasis and cysticercosis elimination program in China. Following the implementation of the policy of aeniasis and cysticercosis elimination and classified guidance, a great success has been achieved in aeniasis and cysticercosis control in Henan Province. With continuous promotion of the opening-up policy and the Belt and Road Initiative, there are still challenges in taeniasis and cysticercosis control. This review summarizes the control progress of taeniasis and cysticercosis and proposes the challenges of taeniasis and cysticercosis control in Henan Province.
Collapse
Affiliation(s)
- T T Jiang
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - P H Ji
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - Z Q He
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - Y L Zhang
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - Y Deng
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - X Chen
- Fangcheng Center for Disease Control and Prevention, Henan Province, China
| | - Y Hong
- Fangcheng Center for Disease Control and Prevention, Henan Province, China
| | - D Y Zhao
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - H W Zhang
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - X M Lin
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - W Q Chen
- Henan Provincial Center for Disease Control and Prevention, Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| |
Collapse
|
47
|
Wang JK, Wei W, Zhao DY, Wang HF, Zhang YL, Lei JP, Yao SK. Intestinal mucosal barrier in functional constipation: Dose it change? World J Clin Cases 2022; 10:6385-6398. [PMID: 35979313 PMCID: PMC9294902 DOI: 10.12998/wjcc.v10.i19.6385] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 03/21/2022] [Accepted: 04/09/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The intestinal mucosal barrier is the first line of defense against numerous harmful substances, and it contributes to the maintenance of intestinal homeostasis. Recent studies reported that structural and functional changes in the intestinal mucosal barrier were involved in the pathogenesis of several intestinal diseases. However, no study thoroughly evaluated this barrier in patients with functional constipation (FC).
AIM To investigate the intestinal mucosal barrier in FC, including the mucus barrier, intercellular junctions, mucosal immunity and gut permeability.
METHODS Forty FC patients who fulfilled the Rome IV criteria and 24 healthy controls were recruited in the Department of Gastroenterology of China-Japan Friendship Hospital. The colonic mucus barrier, intercellular junctions in the colonic epithelium, mucosal immune state and gut permeability in FC patients were comprehensively examined. Goblet cells were stained with Alcian Blue/Periodic acid Schiff (AB/PAS) and counted. The ultrastructure of intercellular junctional complexes was observed under an electron microscope. Occludin and zonula occludens-1 (ZO-1) in the colonic mucosa were located and quantified using immunohistochemistry and quantitative real-time polymerase chain reaction. Colonic CD3+ intraepithelial lymphocytes (IELs) and CD3+ lymphocytes in the lamina propria were identified and counted using immunofluorescence. The serum levels of D-lactic acid and zonulin were detected using enzyme-linked immunosorbent assay.
RESULTS Compared to healthy controls, the staining of mucus secreted by goblet cells was darker in FC patients, and the number of goblet cells per upper crypt in the colonic mucosa was significantly increased in FC patients (control, 18.67 ± 2.99; FC, 22.42 ± 4.09; P = 0.001). The intercellular junctional complexes in the colonic epithelium were integral in FC patients. The distribution of mucosal occludin and ZO-1 was not altered in FC patients. No significant differences were found in occludin (control, 5.76E-2 ± 1.62E-2; FC, 5.17E-2 ± 1.80E-2; P = 0.240) and ZO-1 (control, 2.29E-2 ± 0.93E-2; FC, 2.68E-2 ± 1.60E-2; P = 0.333) protein expression between the two groups. The mRNA levels in occludin and ZO-1 were not modified in FC patients compared to healthy controls (P = 0.145, P = 0.451, respectively). No significant differences were observed in the number of CD3+ IELs per 100 epithelial cells (control, 5.62 ± 2.06; FC, 4.50 ± 2.16; P = 0.070) and CD3+ lamina propria lymphocytes (control, 19.69 ± 6.04/mm2; FC, 22.70 ± 11.38/mm2; P = 0.273). There were no significant differences in serum D-lactic acid [control, 5.21 (4.46, 5.49) mmol/L; FC, 4.63 (4.31, 5.42) mmol/L; P = 0.112] or zonulin [control, 1.36 (0.53, 2.15) ng/mL; FC, 0.94 (0.47, 1.56) ng/mL; P = 0.185] levels between FC patients and healthy controls.
CONCLUSION The intestinal mucosal barrier in FC patients exhibits a compensatory increase in goblet cells and integral intercellular junctions without activation of mucosal immunity or increased gut permeability.
Collapse
Affiliation(s)
- Jun-Ke Wang
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Wei Wei
- Department of Clinical Nutrition and Department of Health Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Dong-Yan Zhao
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Hui-Fen Wang
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Yan-Li Zhang
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Jie-Ping Lei
- Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China
| | - Shu-Kun Yao
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
48
|
Zhou F, Chen F, Pan T, Zhu T, Zhang YL, Zhang P, Tang HR. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma]. Zhonghua Fu Chan Ke Za Zhi 2022; 57:361-369. [PMID: 35658327 DOI: 10.3760/cma.j.cn112141-20220326-00194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To evaluate the survival, complications and prognostic factors in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma treated by primarily radical surgery with or without postoperative adjuvant therapy. Methods: The clinical and pathological data of patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma treated in the Cancer Hospital of the University of Chinese Academy of Sciences from January 2015 to January 2018 were retrospectively analyzed. All patients underwent Querleu-Morrow classification (Q-M classification) C2 radical surgery, including extensive hysterectomy+pelvic lymphadenectomy with or without adjuvant therapy based on postoperative risk factors. Survival rate was calculated by Kaplan-Meier method and survival curve was drawn. Univariate analysis was performed by using the log-rank test to analyze the clinicopathological factors related to the prognosis of patients. Multivariate analysis was performed by using Cox regression method to analyze independent risk factors affecting survival prognosis. Results: (1) The median age of 643 patients with cervical squamous cell carcinoma was 50 years old (45-58 years old). Clinical stage: 260 cases (40.4%, 260/643) of stage Ⅰb2, 383 cases (59.6%, 383/643) of stage Ⅱa2. (2) Among 643 cases underwent Q-M classification C2 surgery, 574 cases (89.3%, 574/643) of them received adjuvant therapy and 184 cases (28.6%, 184/643) of them had grade 3-4 complications after treatment, including 134 cases (20.8%, 134/643) early complications and 66 cases (10.3%, 66/643) late complications. The incidence of grade 3-4 complications in 574 patients received postoperative adjuvant therapy was 30.1% (173/574), which was significantly different from that in 69 patients who received surgery alone (15.9%, 11/69; χ²=6.08, P=0.014). (3) All 643 cases were followed up, and the median follow-up time was 40 months (3-76 months). During the follow-up period, 117 cases (18.2%, 117/643) recurred, including 45 cases (7.0%, 45/643) of local recurrence, 54 cases (8.4%, 54/643) of distant metastasis, and 18 cases (2.8%, 18/643) of local recurrence and distant metastasis. The 5-year progression-free survival (PFS) and 5-year overall survival (OS) rates of patients with stage Ⅰb2 and Ⅱa2 cervical squamous cell carcinoma were 79.9% and 85.5%, respectively. Univariate analysis showed that pelvic lymph node metastasis, para-aortic lymph node metastasis, deep stromal infiltration, and lymph-vascular space invasion were significantly associated with 5-year PFS in patients with stage Ⅰb2 and Ⅱa2 cervical squamous cell carcinoma (all P<0.05). The maximum diameter of tumor, pelvic lymph node metastasis and para-aortic lymph node metastasis were significantly associated with the 5-year OS of cervical squamous cell carcinoma in stages Ⅰb2 and Ⅱa2 (all P<0.05). Multivariate analysis showed that pelvic lymph node metastasis and para-aortic lymph node metastasis were independent factors affecting 5-year PFS and 5-year OS in patients with stage Ⅰb2 and Ⅱa2 cervical squamous cell carcinoma (all P<0.01). Conclusion: Radical surgery is a feasible and effective primary treatment for stagesⅠb2 and Ⅱa2 cervical squamous cell carcinoma, with a high 5-year survival rate and an acceptable complication rate.
Collapse
Affiliation(s)
- F Zhou
- Department of Gynecological Oncology, the Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - F Chen
- School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China
| | - T Pan
- School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China
| | - T Zhu
- Department of Gynecological Oncology, the Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - Y L Zhang
- Department of Gynecological Oncology, the Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - P Zhang
- Department of Gynecological Oncology, the Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - H R Tang
- Department of Gynecological Radiotherapy, the Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China
| |
Collapse
|
49
|
Zhu XH, Tang Q, Xie MY, Xue RY, Zhang YL, Wu Y, Hu X, Yang H, Gao Z. [Numerical simulation modeling of middle ear-eustachian tube ventilation based on Chinese digital visual human body]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2022; 57:452-457. [PMID: 35527436 DOI: 10.3760/cma.j.cn115330-20210530-00311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To establish a three-dimensional model of middle ear-eustachian tube based on Chinese digital visual human dataset, and the deformation and pressure changes of the middle ear-eustachian tube system after eustachian tube opening are simulated by computer numerical simulation. Methods: The first female Chinese Digital Visual Human data was adopted. The images were imported by Amira image processing software, and the images were segmented by Geomagic software to form a three-dimensional model of middle ear-eustachian tube system, including eustachian tube, tympanum, tympanic membrane, auditory ossicles, and mastoid air cells system. The 3D model was imported into Hypermesh software for meshing and analysis. The structural mechanics calculation was carried out by Abaqus, and gas flow was simulated by Xflow. The tissue deformation and middle ear pressure changes during eustachian tube opening were numerically simulated by fluid-solid coupling algorithm. Several pressure monitoring points including tympanum, mastoid, tympanic isthmus, and external auditory canal were set up in the model, and the pressure changes of each monitoring point were recorded and compared. Results: In this study, a three-dimensional model of middle ear-eustachian tube and a numerical simulation model of middle ear ventilation were established, including eustachian tube, tympanum, mastoid air cells, tympanic membrane, and auditory ossicles. The dynamic changes of the model after ventilation could be divided into five stages according to the pressure. In addition, the pressure changes of tympanum and tympanic isthmus were basically synchronous, and the pressure changes of mastoid air cells system were later than that of tympanum and tympanic isthmus, which verified the pressure buffering effect of mastoid. The extracted pressure curve of the external auditory canal was basically consistent with that of tympanometry in terms of value and trend, which verified the effectiveness of the model. Conclusions: The numerical simulation model of middle ear-eustachian tube ventilation established in this paper can simulate the tissue deformation and middle ear pressure changes after eustachian tube opening, and its accuracy and effectiveness are also verified. This not only lays a foundation for further research, but also provides a new research method for the study of middle ear ventilation.
Collapse
Affiliation(s)
- X H Zhu
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Q Tang
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - M Y Xie
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - R Y Xue
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y L Zhang
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y Wu
- Department of Digital Medicine, Biomedical Engineering and Imaging Medicine, Third Military Medical University, Chongqing 400038, China
| | - X Hu
- Department of Digital Medicine, Biomedical Engineering and Imaging Medicine, Third Military Medical University, Chongqing 400038, China
| | - H Yang
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Zhiqiang Gao
- Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| |
Collapse
|
50
|
Zhang YL, Jiang TT, Ji PH, He ZQ, Chen X, Hong Y, Zhao DY, Deng Y, Chen WQ, Zhang HW. [Evaluation of efficiency of different anti-cysticercus antibody test kits for serodiagnosis of cysticercosis]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2022; 34:36-40. [PMID: 35266355 DOI: 10.16250/j.32.1374.2021216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE To evaluate the diagnostic efficiency of four anti-cysticercus IgG, IgG4 or IgM antibody test kits (enzyme-linked immunosorbent assay, ELISA) by different manufacturers, so as to provide insights into the epidemiological investigation and clinical detection of cysticercosis. METHODS Forty serum samples from cerebral cysticercosis patients, 100 serum samples from healthy volunteers, 30 serum samples from paragonimiasis skrjabini patients, 17 serum samples from cystic echinococcosis and 19 serum samples from subcutaneous or cerebral sparganosis patients were collected and detected using anti-cysticercus IgG, IgG4 or IgM antibody test kits (brand A) and the anti-cysticercus IgG antibody test kit (brand B). The sensitivity, specificity and false negative rate of the four kits for detection of cysticercosis were estimated. RESULTS The anti-cysticercus IgG, IgG4 or IgM antibody test kits (brand A) showed 95.00% (38/40), 87.50% (35/40), 7.50% (3/40) sensitivities and 98.00% (98/100), 100.00% (100/100) and 100.00% (100/100) for detection of cysticercosis, while the anti-cysticercus IgG antibody test kit (brand B) presented a 75.00% (30/40) sensitivity and 100.00% (100/100) specificity for detection of cysticercosis. The sensitivity for detection of cysticercosis was significantly higher by the anti-cysticercus IgG antibody test kit (brand A) than by the anti-cysticercus IgG antibody test kit (brand B) (χ2 = 6.28, P < 0.05); however, no significant difference was seen in the specificity by two kits (χ2 = 2.01, P > 0.05). The four ELISA kits showed overall false positive rates of 37.88% (25/66), 22.73% (15/66), 62.12% (41/66) and 15.15% (10/66) for detection of paragonimiasis, echinococcosis and sparganosis (χ2 = 37.61, P < 0.05), and the anti-cysticercus IgG antibody test kit (brand A) presented the highest overall false positive rate for detection of paragonimiasis, echinococcosis and sparganosis (χ2 = 7.56, P' < 0.008), while a higher overall false positive rate was seen for detection of paragonimiasis, echinococcosis and sparganosis by the anti-cysticercus IgG antibody test kit (brand A) than by the anti-cysticercus IgG antibody test kit (brand B) (χ2 = 8.75, P' < 0.008). The four ELISA kits showed false positive rates of 40.00% (12/30), 16.67% (5/30), 76.67% (23/30) and 13.33% (4/30) for detection of paragonimiasis (χ2 = 32.88, P < 0.05) and 21.05% (4/19), 26.32% (5/19), 73.68% (14/19) and 15.79% (3/19) for detection of sparganosis (χ2 = 19.97, P < 0.05), and the highest false positive rates were found by the anti-cysticercus IgM antibody test kit (brand A) for detection of paragonimiasis and sparganosis (all P' < 0.008). However, the four ELISA kits showed comparable false positive rates of 52.94% (9/17), 29.41% (5/17), 23.53% (4/17) and 17.65% (3/17) for detection of echinococcosis (χ2 = 8.24, P > 0.05). In addition, the anti-cysticercus IgM anti-body test kit (brand A) showed false positive rates of 76.67% (23/30), 23.53% (4/17) and 73.68% (14/19) for detection of paragonimiasis, echinococcosis and sparganosis (χ2 = 14.537, P < 0.05), with the lowest false positive rate seen for detection of echinococcosis (χ2 = 14.537, P' < 0.014), while no significant differences were seen in the false positive rate for detection of paragonimiasis, echinococcosis and sparganosis by other three ELISA kits (all P > 0.05). CONCLUSIONS The four anti-cysticercus IgG, IgG4 or IgM antibody test kits exhibit various efficiencies for serodiagnosis of cysticercosis. The anti-cysticercus IgG antibody test kit (brand A) has a high sensitivity for serodiagnosis of cysticercosis; however, it still needs to solve the problems of cross-reaction with other parasitic diseases and stability.
Collapse
Affiliation(s)
- Y L Zhang
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - T T Jiang
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - P H Ji
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - Z Q He
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - X Chen
- Fangcheng Center for Disease Control and Prevention, Henan Province, China
| | - Y Hong
- Fangcheng Center for Disease Control and Prevention, Henan Province, China
| | - D Y Zhao
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - Y Deng
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - W Q Chen
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| | - H W Zhang
- Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, China
- Henan Medical Key Laboratory for Pathogen and Vector of Parasites, Zhengzhou, Henan 450016, China
| |
Collapse
|